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Abstract
The recent surge in incorporation of metallic and metal oxide nanomaterials into consumer 
products and their corresponding use in occupational settings have raised concerns over the 
potential for metals to induce size-specific adverse toxicological effects. Although nano-metals 
have been shown to induce greater lung injury and inflammation than their larger metal 
counterparts, their size-related effects on the immune system and allergic disease remain largely 
unknown. This knowledge gap is particularly concerning since metals are historically recognized 
as common inducers of allergic contact dermatitis, occupational asthma, and allergic adjuvancy. 
The investigation into the potential for adverse immune effects following exposure to metal 
nanomaterials is becoming an area of scientific interest since these characteristically lightweight 
materials are easily aerosolized and inhaled, and their small size may allow for penetration of the 
skin, which may promote unique size-specific immune effects with implications for allergic 
disease. Additionally, alterations in physicochemical properties of metals in the nano-scale greatly 
influence their interactions with components of biological systems, potentially leading to 
implications for inducing or exacerbating allergic disease. Although some research has been 
directed toward addressing these concerns, many aspects of metal nanomaterial-induced immune 
effects remain unclear. Overall, more scientific knowledge exists in regards to the potential for 
metal nanomaterials to exacerbate allergic disease than to their potential to induce allergic disease. 
Furthermore, effects of metal nanomaterial exposure on respiratory allergy have been more 
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thoroughly-characterized than their potential influence on dermal allergy. Current knowledge 
regarding metal nanomaterials and their potential to induce/ exacerbate dermal and respiratory 
allergy are summarized in this review. In addition, an examination of several remaining knowledge 
gaps and considerations for future studies is provided.
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Introduction
Over the past several decades, an extensive amount of scientific attention has been invested 
in the field of nanotechnology. Significant advances have been made in understanding the 
unique behaviors of matter with nano-scale dimensions. This progress has facilitated the 
capacity for manipulation of material properties to optimize their functional utility. 
Subsequently, nanomaterials have proven useful in diverse applications ranging from 
pharmaceutics and energetics to transportation and electronics. The exponential growth of 
the nanotechnology field has left few sectors unaffected by its momentum, as the global 
nanotechnology market has been valued at over $20 billion US (Nanomaterials Future 
Markets 2015). Although the resounding impact of these technological advancements has 
generated comparisons to the impact of the industrial revolution, the expansion of 
nanotechnology has also generated several notable concerns. In addition to the 
environmental, legal, ethical, and regulatory challenges imposed by the expanding presence 
of nanotechnology, the potential risk for adverse health effects following exposure to 
nanomaterials has also become a major concern.
As a result, a unique discipline of toxicology has emerged to evaluate the potential health 
effects of nanomaterials. Nanotoxicology studies have consistently demonstrated that the 
unique properties of nanomaterials that render their industrial functionality also implicate 
unique interactions with biological systems. A general correlation between decreasing size 
and increased toxic potential has been observed for many nanomaterials (Shang et al. 2014). 
However, additional physical and chemical properties of nanomaterials have been implicated 
in their biological activity. Nanomaterials exist in various morphologies (Figure 1) with 
diverse surface textures, and can assume differing degrees of agglomeration. These physical 
properties contribute to variations in their chemical properties, which include surface charge, 
dissolution kinetics, and surface reactivity (Oberdorster et al. 2005; Castranova 2011; Gatoo 
et al. 2014).
One of the greatest challenges presented to nano-toxicologists arises from the discord 
between the rapid emergence of vast quantities of new nanomaterials and the significant 
amount of time and resources required to evaluate the safety of each material individually. A 
novel risk assessment approach proposed to mitigate this issue involves delineation of 
relationships between specific physicochemical properties and toxicological modes of action 
(Kuempel et al. 2012; Braakhuis et al. 2016). Subsequently, emerging materials can be 
categorized by this scheme, providing preliminary safety information and prioritization of 
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resources for in vivo studies (Schulte et al. 2014). Significant advancements have been made 
using this approach with respect to toxic effects on the lungs, but the correlation of 
nanomaterial physicochemical properties with adverse effects on other systems, such as the 
immune system, are less clear.
In addition to protecting the host from both endogenous and exogenous threats, the immune 
system is a critical regulator in hundreds of other disorders, as inflammation is a critical 
component in the pathophysiology of nearly all chronic diseases states (Pawelec et al. 2014). 
Accordingly, deviations in optimal immune functioning can have resounding effects on host 
health, whether polarized towards being either stimulatory or suppressive in nature. One of 
the immunological disorders presenting a significant and continually expanding global 
public health burden is allergy. The term “allergic disease” refers to a collective assortment 
of disorders involving diverse inciting agents, underlying immunological mechanisms, and 
clinical manifestations. However, all hypersensitivity disorders are characterized by 
commonality in hyperactivation of adaptive immune responses directed at otherwise 
innocuous exogenous antigens (Pawankar 2014).
Rates of allergic disease have been on the rise for decades, and the American Academy of 
Allergy, Asthma, and Immunology reports that worldwide, sensitization rates to one or more 
common allergens are approaching 40–50% in school-aged children (AAAAI 2015). In the 
United States, allergic diseases are the sixth leading cause of chronic illness with an annual 
cost exceeding $18 billion US (Centers for Disease Control and Prevention 2017). Although 
the development of allergy is dependent on a multitude of genetic, behavioral, and 
environmental factors, exposures to immunotoxic agents are a major underlying contributor 
to allergic diseases (Boverhof et al. 2008). Immunotoxic agents with the capacity to impact 
allergic disorders generally exert one of two effects. First, the agent can act as an allergen or 
sensitizer. Following exposure to these agents, the resultant adaptive immune response is 
specific to the agent and subsequent encounters trigger allergic reactions. Contrarily, agents 
can augment immunological processes involved in allergic disorders specific to differing 
agent. These agents are often referred to as “adjuvants” or “immuno-modulators” and their 
effects can range from increasing host susceptibility to sensitization, decreasing the allergen 
dose required to induce sensitization, decreasing the dose required to elicit allergic 
responses, or exacerbating the severity of allergic responses (Zunft 1996).
As the nanotechnology market continues to expand and the global prevalence of allergic 
disease continues to increase, the knowledge gap regarding the immunotoxic potential of 
nanomaterials is becoming increasingly relevant. Specifically, the capacity for nanomaterials 
to cause or exacerbate allergic disease remains largely unknown, which is particularly 
concerning with respect to a specific class of nanomaterials. Metal-based nanomaterials (e.g. 
metallic, oxidic, alloy, and salt forms) are one of the classes of nanomaterials being 
produced in the largest quantities. Noteworthy metal nanomaterials, their applications, and 
corresponding rates of production are shown in Table 1. These emerging materials present a 
specific concern with respect to allergy, as many of the metal-based nanomaterials being 
manufactured in large volumes are comprised of metals known to cause allergic contact 
dermatitis (ACD), asthma, and allergy adjuvancy (Warshaw et al. 2013; Schmidt and 
Goebeler 2015).
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Metal nanomaterials are being increasingly incorporated into nano-enabled products and 
consumer goods, increasing the potential for exposures in the general public (Vance et al. 
2015). Although the unknown immune effects of many metal nanomaterials present a risk 
for consumers, workers involved in the manufacture, handling, and transportation of metal 
nanomaterials present a population particularly susceptible to adverse allergic effects. The 
National Science Foundation estimates that by 2020, at least 2 million workers in the United 
States alone will be employed by nanotechnology-related fields (Roco 2011). New 
nanomaterials are continually being developed, and workers are often the first individuals in 
society to encounter emerging materials, and often in much greater quantities than 
consumers. Moreover, occupational settings are known to contribute to the development and 
progression of allergic diseases (Arruda et al. 2005). Of the 24 million Americans affected 
by allergic asthma, 10–25% of adult cases are related to workplace conditions (Petsonk 
2002). Skin allergies are even more common, affecting an estimated 15–20% of the general 
population, wherein an estimated 25–60% of ACD cases are related to occupational settings 
(Diepgen and Coenraads 1999; Peiser et al. 2012).
Several specific concerns have emerged with respect to metal nanomaterials and their 
potential effects on allergic disease. First, the characteristic size profile of metal 
nanomaterials may confer enhanced potential for skin penetration and more efficient 
deposition in the lungs, circumventing one of the major barriers associated with limiting 
adverse immune effects induced by larger-sized metals. Secondly, the exposure threshold 
required for dermal and respiratory sensitization by metal nanomaterials may be lowered as 
a result of their unique chemistry. Lastly, the induction of inflammation and tissue injury 
caused by many metal nanomaterials may serve as an adjuvant, promoting the development 
of allergic disease to environmental allergens or exacerbating the severity of established 
allergic conditions. This review aims to summarize current scientific knowledge regarding 
these concepts. In addition to dermal and respiratory studies that examine specific metal 
nanomaterial effects, studies designed to delineate the role of physical and chemical 
properties in these effects are emphasized. Finally, considerations and knowledge gaps in the 
field are highlighted as potential directions for future research.
Metals and allergic disease
Metals are a class of agents associated with expansively diverse immune effects including 
irritancy, autoimmunity, sensitization, and adjuvancy (Lawrence and McCabe 2002). The 
potential for such diverse biological effects is reflective of the expansive potential speciation 
of metals, which can include elemental forms, ions, salts, and organified compounds 
(Templeton 2015). Moreover, as exemplified by the transition metal series, many metals 
exist in and transition between different oxidation states that have distinctive immunological 
activity (Artik et al. 1999; Crichton 2017). The chemical behavior unique to these potential 
states dictates the molecular and cellular interactions responsible for metal immunogenicity. 
Since many of these properties are known to be altered on the nano-scale, metal-induced 
immune effects with relevance to allergy are detailed, with emphasis on specific processes 
subject to impact by metal nanomaterial physicochemical properties.
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Metals and dermal allergy
The most common metal-induced allergic disorder of the skin is ACD, a T-cell-mediated 
delayed-type hypersensitivity response. Dermal sensitization and the subsequent induction 
of ACD requires several key molecular and cellular events (Figure 2), which have been 
outlined in an adverse outcome pathway (AOP) by the Organization for Economic Co-
operation and Development (OECD) (OECD 2014).
The preliminary requirement for skin sensitization is bioavailability of the sensitizing agent. 
Since a primary function of the skin is to serve as an effective barrier between the host and 
environment, the sensitizing potential of many antigens is limited by their capacity to evade 
this barrier (Jaitley and Saraswathi 2012). Passage through the uppermost layers of the 
epidermis is heavily dependent on antigen physical and chemical properties. Likewise, most 
dermal sensitizers tend to be low molecular weight (LMW, < 500 Daltons) chemicals with 
adequate lipophilicity (logP ~2) (Chilcott and Price 2008; Karlberg et al. 2008). Metals 
associated with skin sensitization present the greatest concern when formulated as soluble 
salts that release ions capable of penetrating the physical barrier presented by the epidermis 
(Di Gioacchino et al. 2007; Kubo et al. 2013).
The next steps in the skin sensitization AOP involve the molecular initiating event of skin 
sensitization-antigen formation. The small size required for antigen passage through the 
stratum corneum is not conducive with cellular recognition (Anderson et al. 2011). As a 
result, most skin sensitizers are referred to as haptens, which must acquire or possess 
inherent chemical reactivity that facilitates binding to carrier molecules (Büdinger et al. 
2000; Chipinda et al. 2011). This process generates adequate size for recognition by an 
antigen-presenting cell (APC). The APC most frequently implicated in dermal sensitization 
is the resident dendritic cell (DC) of the epidermis, the Langerhans cell (LC) (Thyssen and 
Menne 2010).
In addition to uptake of the hapten/carrier complex, activation of LC requires an additional 
antigen-nonspecific signal indicative of an elevated threat level. Many mediators capable of 
fulfilling this signal are released by non-immune cells including keratinocytes in response to 
injury (Dearman and Kimber 2003). Presence of both antigen-specific and nonspecific 
signals induce LC maturation, upregulation of co-stimulatory molecules, antigen processing, 
and migration to the lymph nodes (Tončić et al. 2011).
Once the LC reaches the lymph nodes, the processed hapten is presented via major 
histocompatibility Class I (MHC I) molecules to naïve CD8+ T-lymphocytes until 
recognition occurs by antigen-specific T-cell receptor (TCR). Given adequate costimulatory 
signals from the LC, T-lymphocytes undergo proliferation producing a pool of clonal 
antigen-specific effector T-cells. The T-cells enter the circulation, and following resolution 
of inflammation, a subset of these effector cells will survive and become memory T-cells, 
completing the process of sensitization.
Upon future exposures to the allergen, memory and effector T-cells are recruited to the site 
of exposure where CD8+ T-cells exhibit immediate cytotoxic effector functions. CD4+ T-
helper (TH) of the TH1 phenotype have regulatory roles in ACD and produce high levels of 
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the cytokines interleukin (IL)-2 and interferon (IFN)-γ, contributing to inflammatory cell 
recruitment (Sasseville 2008; Tončić et al. 2011). Within 48 h, the inflammatory process 
originally orchestrated to destroy the antigen results in the clinical manifestations of ACD, 
including localized skin redness, swelling, and itching at the site of allergen contact.
Metals are among the most common inducers of ACD in the general population. Patch test 
studies have generated data from thousands of subjects and reveal that the most common 
inducers of metal ACD are nickel, gold, cobalt, and chromium (Belloni Fortina et al. 2015). 
Interestingly, studies using subjects exclusive various geographical locations have 
demonstrated that these four metals are consistently problematic with respect to ACD 
worldwide (Kanerva et al. 2000; Mattila et al. 2001; Goon and Goh 2005; Cheng et al. 2008; 
Davis et al. 2011; Nonaka et al. 2011; Khatami et al. 2013; Mahler et al. 2014; Kim et al. 
2015; Malinauskiene et al. 2015; Linauskiene et al. 2017). Though less frequently associated 
with ACD, copper, aluminum, and platinum group metals are also known to cause skin 
allergy in some individuals (Hostynek et al. 1993; Bergfors et al. 2005; Faurschou et al. 
2011; Fage et al. 2014).
Metals and respiratory allergy
Metals are also associated with respiratory allergy and IgE-mediated asthma. An AOP 
specific to the events of respiratory sensitization has not been adopted by the OECD, but 
many of the same steps of the dermal sensitization AOP are involved in the development of 
asthma. Accordingly, bioavailability of the sensitizing agent is also a preliminary limiting 
factor in respiratory sensitization potential. Since the primary function of the respiratory 
tract is to facilitate gas exchange between the host and environment, it is particularly 
vulnerable to adverse effects from a diverse assortment of agents in the inhalable (< 20 μm) 
and respirable size range (< 10 μm) (Elder and Oberdorster 2006). Likewise, bioavailable 
metals capable of sensitizing the respiratory tract are not limited to ions, like in the skin 
(Linde et al. 2017). Respirable metals may be encountered as particulate matter, vapors, or 
fumes and can be constituents of compounds including oxides, sulfides, and salts, or as 
complexes with ammonia, carbon monoxide, and organic nitrogen (Malo et al. 2013).
Since both low and high molecular weight (HMW) agents are capable of inducing asthma, 
the molecular initiating events of respiratory sensitization may differ accordingly. Similar to 
the skin, pulmonary immune responses following inhalation of metals can be nonspecific 
and self-limiting, or can result in the recruitment of the adaptive immune system. Lung-
resident DC take up antigen, and given adequate second signals, the antigen is processed and 
DC migrate to the lung-draining lymph nodes. Here, the peptide is presented to naïve CD4+ 
T-lymphocytes along with costimulatory molecules, resulting in the preferential expansion 
of the TH−2 phenotype lymphocytes. These cells produce high levels of IL-4, IL-5, and 
IL-13, and stimulate isotype switching and allergen-specific IgE-production by B-cells. The 
Fc portion of secreted IgE is bound to FceRI receptors present on tissue-resident mast cell 
surfaces and circulating basophils, exposing the antigen-recognizing motif, completing the 
sensitization process (Verstraelen et al. 2008).
Upon subsequent encounters, the allergen is bound by allergen-specific IgE on the surface of 
mast cells and basophils. Binding induces crosslinking of receptors and the subsequent 
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release of preformed mediators such as histamine, beginning the anaphylactic cascade 
responsible for the early asthmatic reaction experienced minutes after antigen encounter. 
Acute clinical manifestations of allergic asthma range from rhinitis and bronchoconstriction 
to anaphylactic shock. The late phase asthmatic response occurs 4–6 h later as a result of 
mast cell mediators and recruitment of inflammatory cells (Possa et al. 2013). Clinical 
presentations of the late phase asthmatic response tend to be more severe than early phase 
responses, and include excessive mucus production, increased vascular permeability, and 
airway constriction. Chronic cycles of allergic inflammation and subsequent repair are 
associated with structural alterations in the airways that can have physiological implications, 
such as a decline in lung function (Erle and Sheppard 2014).
Compared to metal-induced ACD, metal-induced asthma occurs far less frequently. Cases 
tend to be isolated to individuals working in occupations involving metalwork where metal 
fumes, dust, or vapors are generated and inhaled (Wyman and Hines 2018). Nickel, 
chromium, cobalt, vanadium, zinc, platinum and aluminum have all been associated with 
cases of occupational asthma (Musk and Tees 1982; Hong et al. 1986; Malo et al. 2013). 
However, metal-specific IgE has only been implicated in cases caused by nickel, platinum, 
chromium, and cobalt (Malo et al. 1982; Murdoch et al. 1986; Shirakawa et al. 1988, 1990, 
1992; Kusaka et al. 1996). Metal-specific IgG molecules have also been implicated in cases 
of cobalt and platinum-induced asthma (Pepys et al. 1979; Cirla 1994). The presence of 
metal-specific IgE has also been confirmed in the absence of asthmatic symptoms, 
emphasizing the potential for numerous immunological mechanisms in metal-specific 
asthma (El-Zein et al. 2005; Tončić et al. 2013).
Metals and allergy adjuvancy
In addition to their potential to induce sensitization, metals are also associated with the 
capacity to modulate allergic responses to nonmetal allergens. Contrasted with the 
consistent, sequential series of cellular processes involved in allergic sensitization and 
elicitation, adjuvant effects can emerge as a result of various mechanisms in various phases 
of allergic disorders (Figure 3).
An example of metal adjuvant effects on the development of adaptive immune responses is 
best demonstrated by aluminum hydroxide, which is one of the most frequently used vaccine 
adjuvants. When administered with poorly-immunogenic antigens, aluminum hydroxide 
induces adequate stimulation of the innate immune system to generate antigen-specific 
immunological memory. Mechanisms of immunopotentiation associated with aluminum 
hydroxide include triggering release of alarmins, activation of inflammasomes (intracellular 
multi-protein complexes involved in innate immune responses), and DC activation; however, 
numerous other mechanisms including immune cell recruitment and activation, modulated 
cytokine production, and altered antigen delivery kinetics, can also enhance sensitization 
(Naim et al. 1997; Aimanianda et al. 2009).
Similarly, metals are also associated with adjuvant effects on established allergic conditions, 
as demonstrated by metal-rich ambient air pollution, which is known to exacerbate the 
severity of asthmatic responses to environmental allergens (Gavett et al. 2003; Schaumann et 
al. 2004). Adjuvant effects on allergic elicitation can involve mechanisms including 
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induction of pulmonary oxidative stress, enhanced degranulation of mast cells, and 
recruitment of inflammatory cells (Walczak-Drzewiecka et al. 2003; Ghio 2008).
Unique properties associated with metal immune effects
Metals are known to induce many unique immune effects implicated in allergic disease. 
With respect to sensitization, the modulation of innate immune reactivity by some metals 
has been associated with their immuno-genicity. For example, some metal ions are known to 
produce functional mimicry of pathogen-associated molecular patterns (PAMP) (Schmidt 
and Goebeler 2015). Gold ions have the capacity to bind and activate Toll-like receptor 
(TLR)-3, while nickel, cobalt, and palladium ions have the capacity to bind and activate 
human TLR-4 (Schmidt et al. 2010; Rachmawati et al. 2013, 2015). The subsequent 
induction of pro-inflammatory signaling generates the antigen nonspecific signals required 
for DC activation, promoting sensitization.
Metals are also known to modulate mechanisms of communication between innate and 
adaptive immune cells. Accordingly, antigen presentation is another step in allergic 
sensitization that is subject to interference by metals. Beryllium and noble metals have been 
shown to induce structural alterations in MHC molecules, impacting subsequent interactions 
with TCR (de Wall et al. 2006; Falta et al. 2013). Similarly, peptide-independent linking of 
MHC and TCR by nickel has been demonstrated (Gamerdinger et al. 2003; Thierse et al. 
2005). Adaptive immune responses can also be affected by metals, as demonstrated by CD4+ 
nickel-specific T-cell clones, which were shown to cross-react when presented with other 
transition metals including copper and palladium (Moulon et al. 1995; Pistoor et al. 1995).
Many of the unique immune effects associated with metals emerge as a result of their 
capacity to alter molecular and cellular interactions on a biochemical level. Accordingly, 
their modulation of processes involved in allergic disease is critically dependent on 
physicochemical properties including special geometry, oxidation state, and solubility 
(Schuhmann et al. 1990; Kinbara et al. 2011). Many of these properties are altered in 
nanoparticulate form, suggesting that metal nanomaterials may exhibit novel mechanisms of 
immune interaction with implications for allergic disease.
Metal nanomaterials and dermal hypersensitivity
The potential for adverse immune effects following dermal exposure to metal nanomaterials 
is a growing concern due to their increasingly frequent incorporation into consumer goods 
intended to have prolonged contact with the skin (Yang and Westerhoff 2014). The unique 
optical properties of titanium dioxide nanoparticles (TiO2 NP) and zinc oxide nanoparticles 
(ZnO NP) have led to their incorporation in sunscreens and cosmetics for their protective 
effects against ultraviolet radiation (UVR) (Smijs and Pavel 2011; Yoshioka et al. 2017). 
Silver nano-particles (AgNP) are being incorporated into clothes, medical textiles, toys, and 
cleaning products due to their antimicrobial properties, and silica-based nanoparticles 
(SiNP) have been frequently used in cosmetics and as a coating material to alter the 
properties of other materials (Contado 2015; Tulve et al. 2015). Likewise, the dermal effects 
of TiO2 NP, ZnO NP, AgNP, and SiNP are a particular concern with respect to the general 
public (Weir et al. 2012). These nanomaterials are also a concern for workers, but other 
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metal nanomaterials with high rates of production (listed in Table 1) are also associated with 
dermal exposures in the workplace.
The potential for metal nanomaterials to penetrate the skin, induce dermal sensitization, and 
modulate skin allergy development/responses are the three main areas discussed in this 
section with respect to size and other physicochemical properties. In correspondence with 
the review of the literature, Table 2 summarizes studies characterizing effects of individual 
metal nanomaterials on skin allergy. Table 3 summarizes studies designed to examine effects 
of physicochemical properties of metal nanomaterials on dermal allergy. Table 4 highlights 
key events involved in dermal sensitization and elicitation that have been shown to be 
subject to modulation by metal nanomaterials and their corresponding physicochemical 
properties.
Skin penetration and translocation studies
Adverse immune effects following dermal exposure to an agent are heavily dependent on the 
degree to which the skin protects from its entry into the body. Likewise, one mechanism by 
which dermal exposure to metal nanomaterials may lead to increased potential for adverse 
immune effects compared to larger-sized metals is by size-mediated evasion of skin barrier 
function. Although it seems logical that the small size of nanomaterials would inherently 
provide increased opportunity for absorption via the skin, there is currently no general 
consensus on the skin-penetrating capabilities of nanomaterials as a collective class of 
agents (Vogt et al. 2006; Baroli 2010; Try et al. 2016).
Numerous studies have demonstrated that metal nanomaterials (< 100 nm) can penetrate 
skin in various in vivo and in vitro models. Iron-based nanoparticles (FeNP), gold 
nanoparticles (AuNP), palladium nanoparticles (PdNP), nickel nanoparticles (NiNP), AgNP, 
SiNP, and metal-based quantum dots (QD) have all been associated with penetration of the 
skin (Baroli et al. 2007; Chu et al. 2007; Filon et al. 2011, 2016; Labouta et al. 2011; Hirai 
et al. 2012a; Rancan et al. 2012; George et al. 2014; Crosera et al. 2016; Kraeling et al. 
2018). Moreover, many of these studies have established a relationship between decreased 
particle size and increased potential for skin permeation (Ryman-Rasmussen et al. 2006; 
Sonavane et al. 2008; Matsuo et al. 2016; Raju et al. 2018). Hydrophobicity, surface charge, 
and morphology are additional properties that have been shown to be influential in the 
capacity for these nanomaterials to pass through the stratum corneum (Rancan et al. 2012; 
Lee et al. 2013; Iannuccelli et al. 2014; Fernandes et al. 2015; Tak et al. 2015; Mahmoud et 
al. 2018).
By comparison, the majority of studies investigating the skin-penetrating potential of metal 
nanomaterials have been conducted with ZnO NP and TiO2 NP and have not generated 
equally consistent findings. Numerous studies have demonstrated that the stratum corneum 
effectively restricts passage of TiO2 NP, irrespective of size shown to facilitate penetration of 
the skin by other metal nanomaterials. Repeated application of different forms of TiO2 NP 
did not lead to skin penetration in hairless rats, elevated levels of titanium in lymph nodes of 
minipigs, or penetration of human skin transplanted onto immunodeficient mice (Kiss et al. 
2008; Sadrieh et al. 2010; Adachi et al. 2013). Although TiO2 NP were shown to accumulate 
in and around furrows of the skin, microscopic analysis was used to confirm that 20–100 nm 
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TiO2 NP remained restricted to the uppermost 3–5 layers of corneocytes of the stratum 
corneum (Lademann et al. 1999; Pflücker et al. 1999; Gontier et al. 2008; Senzui et al. 
2010). Contrarily, a few studies using TiO2 NP-containing sunscreens have reported 
penetration of particles into the viable epidermis of human skin (Tan et al. 1996; Coelho et 
al. 2016; Naess et al. 2016).
Similar observations have been reported for ZnO NP. Despite associations with hair follicles, 
ZnO NP were not capable of penetrating the stratum corneum in multiple models, 
irrespective of alterations in size, morphology, and surface characteristics (Schulz et al. 
2002; Zvyagin et al. 2008; Leite-Silva et al. 2013). However, ion release from ZnO NP and 
ZnO NP-containing sunscreens has been observed, highlighting a potential risk associated 
with soluble metal nanomaterials (Holmes et al. 2016).
Adverse effects following dermal exposure to nanomaterials may result from penetration of 
the particulate material or ions released from the parent material. Likewise, physicochemical 
properties of interest may be differentially implicated in effects associated with soluble and 
insoluble metal nanomaterials. With respect to soluble materials, properties associated with 
accelerated ion release may indicate increased potential for skin penetration (Lansdown 
1995; Hostynek 2003; Thyssen and Menne 2010). The rate of ion release is proportional to 
specific surface area (SSA; surface area per mass unit), which is exponentially increased on 
the nano-scale (Laudańska et al. 2002; Zhang et al. 2011; Larese Filon et al. 2015). This 
concept explains the observation that application of sunscreens containing ZnO NP caused 
greater increases in blood, urine, and organ Zn ion levels than sunscreens containing larger-
sized ZnO particles (Gulson et al. 2010, 2012; Osmond-McLeod et al. 2014). Moreover, the 
manipulation of properties with implications for dissolution potential, such as particle 
coating, vehicle, and suspension pH have been shown to promote Zn ion release from ZnO 
NP following dermal exposure (Leite-Silva et al. 2013; Holmes et al. 2016).
Although penetration through corneocytes of the stratum corneum is the primary pathway 
associated with skin penetration by materials, appendages including hair follicles, sebaceous 
glands, sweat glands, and skin folds can mediate an additional mechanism of skin 
penetration. This pathway has notable relevance to nanomaterials, as evidenced by the utility 
of the trans-follicular delivery route for nano-scale pharmaceutics and vaccines (Mahe et al. 
2009). Compared to the thickness of the stratum corneum, which measures 10–20 mm, hair 
follicles can reach a tissue depth of 2000 mm (Toll et al. 2004). Since the base of hair 
follicles extends into the dermis and receives generous lymph and blood supply, they may 
promote access into the circulation (Elder et al. 2009). Moreover, hair follicles can serve as a 
potential reservoir, promoting accumulation of nanomaterials. Retention in hair follicles can 
extend the duration of exposure 10-fold, raising specific concerns for continual ion release 
(Lademann et al. 2006, 2009, 2015; Patzelt et al. 2011; Mahmoud et al. 2017). This pathway 
of skin penetration may also favor immune responses since hair follicles are surrounded by 
dense networks of LC and specialized keratinocyte subpopulations known to have critical 
roles in the early events of sensitization (Toews et al. 1980; Vogt et al. 2006; Nagao et al. 
2012).
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The diameter of hair follicles can vary greatly in response to anatomical location, but the 
smallest follicles tend to be located on the forehead and forearm and measure between 66 
and 78 mm (Otberg et al. 2004). Interestingly, the optimal size for penetration of hair 
follicles is significantly larger than the < 100 nm size range associated with increased skin 
penetration of several metal nanomaterials. Particles with 600–700 nm diameter have been 
shown to deposit in the deepest depths of hair follicles, suggesting that agglomerates of 
nanomaterials in this size range are potentially more hazardous than primary particles 
(Patzelt et al. 2011; Lademann et al. 2015). Furthermore, preferential accumulation in 
follicles has been observed in hydrophobic and neutrally-charged nanomaterials (Mahmoud 
et al. 2017).
Although physicochemical properties of metal nanomaterials have been shown in some 
instances to impact skin penetration, an assortment of host factors can also impact this 
process. Variations in epidermal thickness, integrity, degree of hydration, and skin pH, all of 
which may further differ between gender, can greatly influence skin permeability (Sandby-
Moller et al. 2003; Senzui et al. 2010; de Matteis et al. 2016). However, the role of disrupted 
skin barrier integrity is one of the most commonly-examined host factors with applicability 
to allergic disease since skin permeability can be increased 4–100 times in individuals with 
skin allergy (Larese Filon et al. 2016).
Scratching to alleviate itching associated with allergic skin lesions leads to mechanical 
damage to the upper layers of skin. Similar degrees of damage have been shown to increase 
in vivo penetration of some metal nanomaterials in humans and rodents (Zhang and 
Monteiro-Riviere 2008; Gopee et al. 2009; Ravichandran et al. 2011; Prow et al. 2012). In 
vitro simulations using a human skin model called the Franz Method have demonstrated 
increased capacity for passage through damaged skin by 25 nm AgNP, 6 nm PtNP, 5 nm 
rhodium nanoparticles (RhNP), 10 nm PdNP, 78 nm NiNP, and 80 nm CoNP (Larese et al. 
2009; Larese Filon et al. 2013; Mauro et al. 2015; Crosera et al. 2016; Filon et al. 2016). 
Contrarily, studies have shown that penetration of various sizes of TiO2 NP and ZnO NP are 
not increased in skin damaged by chemical irritants, tape-strip-ping, hair removal, or 
mechanical force (Senzui et al. 2010; Lin et al. 2011; Miquel-Jeanjean et al. 2012; Crosera 
et al. 2015; Xie et al. 2015; Leite-Silva et al. 2016).
A few in vivo studies have also investigated effects of skin barrier dysfunction resulting from 
existing skin allergy on the penetration of metal nanomaterials (Larese Filon et al. 2016). In 
a mouse model of skin allergy, ZnO NP skin penetration of allergic skin was size-
dependently increased, as 240 nm ZnO particles did not penetrate the skin to a similar 
degree as 20 nm ZnO NP (Ilves et al. 2014). Studies using nonmetal nanomaterials have also 
demonstrated that penetration of nanomaterials in allergic skin is size-dependent (Try et al. 
2016). ZnO NP were also shown to penetrate allergic skin ex vivo using human skin samples 
(Szikszai et al. 2011). Contrarily, application of 35 nm ZnO NP to skin of living human 
subjects with atopic dermatitis did not lead to penetration into viable skin (Lin et al. 2011). 
Discrepancies between these studies may be reflective of varying exposure durations, as the 
study reporting penetration involved continuous exposure of up to 2 weeks, compared to the 
4-hr exposure wherein no penetration was observed.
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Comparatively, equally prolonged exposure to AgNP-containing textiles did not lead to 
increased skin penetration in individuals suffering from atopic dermatitis compared to 
control subjects. Sleeves containing silver particles (30–500 nm) were worn by human 
subjects for 8 h a day for 5 consecutive days, following which levels of AgNP and 
aggregates in the skin were quantified. Compromised skin barrier was not associated with 
increases in AgNP skin accumulation; moreover, no differences in urine Ag levels were 
observed, indicating that atopic dermatitis did not impact the absorption of ions released 
from the textiles either (Pluut et al. 2015; Bianco et al. 2016).
Discrepancies in findings regarding the importance of skin barrier integrity on metal 
nanomaterial skin penetration may be explained by several observations. The diverse degrees 
of epidermal barrier function disruption between studies represent a potential source of 
variation. Complete ablation of epidermal function is only observed in response to severe 
burns and lacerations; likewise, the diverse mechanisms of experimentally-induced 
disruptions of the stratum corneum should be compared cautiously. In addition, the 
pathogenesis of atopic dermatitis between experimentally-induced animal models and 
humans may explain some discordant findings. The severity of lesions between subjects of 
human studies is also subject to extreme variation, as well. Since chronic skin inflammation 
can result in epidermal thickening, enhanced barrier function is not uncommon in many skin 
disorders (Nohynek et al. 2007). Lastly, differences in exposure conditions and duration, test 
material formulation, and method of penetration assessment can also serve as a source of 
variation in conclusions between studies. A notable distinction should be made between test 
materials, since some studies used pristine metal nanomaterials, and others used 
commercially-available TiO2 NP/ZnO NP-containing sunscreens. As noted by Gulson et al. 
(2012), their observations regarding ZnO NP skin penetration may have been subject to 
modulation by excipients of the commercial sunscreens used in their study. The sunscreen 
contained isopropyl myristate, a chemical known to enhance the permeability of the skin, as 
well as EDTA, a chelating agent which may have influenced the release of ions from 
ZnONP.
In addition to nanomaterial properties and host factors known to influence the capacity for 
metal nanomaterials to penetrate the skin, environmental factors may also impact this 
process. One environmental factor with particular relevance to metal nanomaterials and their 
use in sunscreens is UVR. Although high levels of UV exposure and subsequent sunburn can 
significantly disrupt epidermal barrier function, low doses of UV exposure are also known to 
compromise the integrity of the epidermis (Wolf et al. 1993; Holleran et al. 1997; Biniek et 
al. 2012). Accordingly, several studies have shown that UV exposure prior to topical 
application of nanomaterials results in greater depth of penetration by ZnO NP, TiO2 NP, and 
QD (Mortensen et al. 2008; Monteiro-Riviere et al. 2011; Mortensen et al. 2013). Moreover, 
UVR can induce alterations in physicochemical properties of metal nanomaterials that may 
facilitate their passage through the stratum corneum, such as agglomerate disaggregation and 
ion release (Martorano et al. 2010; Bennett et al. 2012; Zhou et al. 2012; Ma et al. 2014).
Simultaneously, UVR-induced photoactivation of some metal nanomaterials can facilitate 
their penetration of the skin. In vitro, UVR-induced ROS production by TiO2 NP, QD, and 
ZnO NP has been associated with DNA damage, lipid peroxidation, and mitochondrial 
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permeability in skin cells (Tiano et al. 2010; Wang et al. 2013; Petersen et al. 2014; 
Mortensen et al. 2015; Xue et al. 2015, 2016). Subsequent cytotoxicity to dermal fibroblasts, 
keratinocytes, and melanocytes is another mechanism by which skin barrier integrity can 
become compromised as a result of UVR. In vivo, UVR-induced photoactivation of TiO2 NP 
has been associated with increased adherence to the skin, structural rearrangement of the 
lipid bilayer, and facilitation of large molecule transdermal penetration (Bennett et al. 2012; 
Turci et al. 2013; Peira et al. 2014; Pal, Alam, Chauhan, et al. 2016; Pal, Alam, Mittal, et al. 
2016). Since the degree of ROS produced in response to UVR has been associated with 
nanoparticle surface area and reactivity, other related properties such as size, degree of 
agglom-eration, and surface modification may also contribute to skin penetration following 
UVR exposure (Shen B et al. 2006; Jassby et al. 2012; Yin et al. 2012; Xiong et al. 2013).
Although UVR may contribute to adverse effects following dermal exposure to metal 
nanomaterials by facilitating skin penetration, it may also present a unique concern with 
respect to allergy. Many signaling pathways and pro-inflammatory mediators involved in 
sensitization have been associated with UVR-dependent photoactivation of metal 
nanomaterials (Murray et al. 2013; Rancan et al. 2014). Moreover, UVR is known to 
modulate the immune status of the skin by a number of mechanisms. For example, UVA and 
UVB are known to augment costimulatory molecule expression, compromise antigen 
presentation, and induce apoptosis of LC (Rattis et al. 1998; Seite et al. 2003; Schwarz 
2005). Subsequent effects on the immunological fate of metal nanomaterials on the skin 
have been demonstrated. In a mouse model, significant depletion of LC (~80%) following 
UVR exposure increased skin penetration of QD, but resulted in lower levels of metal ion 
constituents in the lymph nodes (Mortensen et al. 2013).
Skin sensitization studies
The skin sensitizing potential of metal nanomaterials has been investigated in a few studies 
using traditional in vivo approaches. SiO2 NP, ZnO NP, and TiO2 NP have all been 
incorporated into the Local Lymph Node Assay (LLNA) (Mandervelt et al. 1997; Basketter 
et al. 1999). Accordingly, it was demonstrated that topical exposure to 100 nm mesoporous 
and colloidal SiO2 NP, 7 nm SiO2 NP, and ZnO NP were not capable of inducing the 3-fold 
increase in lymphocyte proliferation associated with classification as a dermal sensitizer 
(Choi et al. 2011; Lee et al. 2011; Kim et al. 2016). Similarly, topical exposure to 25 nm 
TiO2 NP did not induce dermal sensitization in multiple studies; however, subcutaneous 
injection of equal doses resulted in significant increases in lymphocyte proliferation, 
suggesting that the inability for TiO2 NP to penetrate the skin might be a limiting factor in 
the potential to induce dermal sensitization (Park et al. 2011; Auttachoat et al. 2014).
The guinea pig maximization test (GPMT) is another in vivo technique used to evaluate 
dermal sensitization potential that has been employed in the investigation of several metal-
based nanomaterials. In one study, five UV-absorbing materials containing SiO2 NP, ZnO 
NP, and TiO2 NP were assessed. One out of 10 animals exhibited slight erythema following 
topical exposure to the ZnO NP and TiO2 NP-containing agents, leading to their 
classifications as mild skin sensitizers (Piasecka-Zelga et al. 2015). In another study, 1 of 20 
animals exhibited discrete patchy erythema following intradermal injection with 10 nm 
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AgNP, leading to its classification as a weak skin sensitizer (Kim et al. 2013). Similarly, 
AgNP were classified as a Grade II (mild sensitizer) after 2 of 10 guinea pigs exhibited 
lesions 48 h after application of AgNP-containing sterile gauze (Zelga et al. 2016). However, 
similar AgNP-containing dressings were actually shown to improve the healing of burn 
wounds in rats over an 18-d period as compared to rats with dressings lacking AgNP, but the 
study only examined the localized effects (Pannerselvam et al. 2017). The GPMT has also 
been used to demonstrate that surface-modified FeNP and hydroxyapatite nanoparticles did 
not induce skin sensitization (Geetha et al. 2013; Mohanan et al. 2014).
The sensitization potential of 5 and 10 nm AgNP was investigated by Hirai et al. (2016) in a 
mouse model. Mice were injected with AgNP or Ag ions and lipopolysaccharide (LPS) once 
a week for 4 weeks, and then intradermally challenged. Interestingly, mice administered Ag 
ions in the sensitization phase did not develop ear swelling following challenge with any 
form of Ag. Contrarily, AgNP exposure induced sensitization, wherein the smaller AgNP 
appeared to have stronger sensitizing potential, which was dependent on CD4+ T-cells and 
IL-17a, but not IFNγ. Moreover, ear swelling was observed in response to additional sizes 
of AgNP (50 and 100 nm) and Ag ions, suggesting that the immune response is not 
nanoparticle-specific. Further examination revealed that 3 nm NiNP was also capable of 
inducing sensitization in the model, whereas minimally-ionizable 10 nm AuNP and 10 nm 
SiNP were not (Hirai et al. 2016).
In addition to in vivo approaches to assess skin sensitization, three non-animal alterative 
assessment methods based on different steps of the skin sensitization AOP are currently 
validated by the OECD. While metal nanomaterials have not been incorporated into any of 
the assays, studies with similar cell lines and endpoints have indicated that many metal 
nano-materials can induce effects similar to those of other skin sensitizers.
The Direct Peptide Reactivity Assay (DRPA) is an in chemico assay based on the 
requirement for haptens to bind skin proteins to acquire immunogenicity. Accordingly, the 
molecular imitating event of dermal sensitization is evaluated by quantification of reactivity 
of an agent towards synthetic lysine and cysteine residues (Gerberick et al. 2004). While 
some studies have investigated metal nanomaterials and their interactions with proteins and 
specific amino acids, implications for their capacity to form hapten/carrier complexes are 
still unclear. However, cysteine has been associated with decreased stability, increased 
dissolution, and accelerated ion release from metal alloy nanoparticles and AgNP (Hahn et 
al. 2012; Ravindran et al. 2013; Siriwardana et al. 2015). Moreover, various amino acids 
have been associated with preferential binding affinities with respect to AuNP size and TiO2 
NP surface charge, supporting a role for multiple physicochemical properties in the 
molecular initiating event of skin sensitization (Liu et al. 2016; Shao and Hall 2016).
The second validated in vitro assay for determination of skin sensitizing potential involves 
evaluation of the keratinocyte response to test agents, since they are a source of numerous 
mediators that facilitate LC migration, antigen presentation, and T-cell activation during 
sensitization (Kimber and Cumberbatch 1992). Since many of these mediators are released 
in response to sensitizer-induced activation of the antioxidant/electrophile sensing pathway 
Keap1/Nrf2/ARE, its activation is suggestive of potential for the test agent to contribute to 
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the cellular response of the sensitization AOP (Natsch and Emter 2008; 2016; Ramirez et al. 
2014). The human keratinocyte cell line associated with this assay, HaCaT, has been 
frequently used to investigate potential metal nanomaterial effects on the skin in vitro. 
Correspondingly, PdNP, AuNP, and PtNP have all been shown to activate the Nrf2 pathway 
in keratinocytes in vitro (Goldstein et al. 2016; Tsuji et al. 2017). Similarly, zinc-containing 
QD, ZnO NP, and CuO NP have all been shown to alter expression of several specific genes 
associated with the Nrf2 pathway, including HMOX1 (Rice et al. 2009; Romoser et al. 2011; 
Lee et al. 2012).
Prior to the establishment of Nrf2 pathway involvement in keratinocyte responses to skin 
sensitizers, cytokine release by keratinocytes in vitro was evaluated as an indicator of 
sensitizing potential (Jung et al. 2016; Koppes et al. 2017). Tumor necrosis factor (TNF)-α 
is a keratinocyte-derived cytokine involved in sensitization and is critically involved in skin 
sensitization by chromium and nickel (Lisby et al. 1995; Wang et al. 2007). Dose-dependent 
TNFα release has been noted following keratinocyte exposure to AgNP, QD, and ZnO NP, 
indicating high doses may promote LC maturation and dermal sensitization (Samberg et al. 
2010; Romoser et al. 2011; Jeong et al. 2013). IL-18 and IL-1β (cytokines critical for LC 
activity) have also been shown to be increased by QD, SiO2 NP, TiO2 NP, and AgNP 
(Ryman-Rasmussen et al. 2007; Samberg et al. 2010; Yazdi et al. 2010; Romoser et al. 2011; 
Hiroike et al. 2013; Zhang and Monteiro-Riviere 2019).
Another mediator involved in skin sensitization that is differentially-released by keratino-
cytes in response to irritants and sensitizers is IL-1α (Coquette et al. 2003; Koppes et al. 
2017). Though it can also be actively secreted after inflammasome activation, IL-1α is an 
intracellular molecule that functions as an alarmin (Ansel et al. 1988). During programed 
cell-death, IL-1α remains associated with chromatin and its sequestration prevents effector 
functions. Contrarily, under necrotic conditions, it is passively released and bioactive. 
Accordingly, the mechanism of metal nanomaterial-induced keratinocyte cytotoxicity may 
significantly impact the development of ACD as a result of differential IL-1α release. 
Although mechanisms associated the preferential induction of necrosis or apoptosis by 
nanomaterials have yet to be established, some properties have been correlated to these 
effects (de Stefano et al. 2012; Mohammadinejad et al. 2019). For example, surface charge 
of 1.5 nm AuNP was demonstrated to be responsible for the mechanism of cell death in 
HaCaT cells in vitro. Charged AuNP led to disruptions in mitochondrial membrane potential 
and intracellular calcium levels causing apoptosis, whereas neutral AuNP were associated 
with necrotic cell death (Schaeublin et al. 2011). Preferential HaCaT apoptosis or necrosis 
has also been associated with AgNP surface coating and TiO2 NP crystal phase (Braydich-
Stolle et al. 2009; Bastos et al. 2016). Collectively, these findings assert that surface 
chemistry/reactivity of metal nanomaterials may be a critical property in determining 
whether dermal exposure results in irritation responses or sensitization.
The last validated alternative approach to evaluate skin sensitizing potential involves 
assessment of the potential for an agent to induce upregulation of activation markers (CD 86 
and CD 54) on human APC. However, since the recommended cell lines for these assays 
(THP-1 and U937) are representative of general DC and not skin-specific DC, these studies 
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will be discussed in the in vitro section of this review, as they may also apply to respiratory 
sensitization and augmentation of allergy.
Very few studies have been conducted to investigate metal nanomaterial effects specific to 
LC. However, topical exposure to < 100 nm AgNP in guinea pigs was shown to increase the 
number of LC at the site of exposure in a dose- and time-dependent manner (Korani et al. 
2011). This observation is relevant to skin sensitization since the concentration of LC 
present in the skin has been correlated with increased susceptibility to ACD development. 
Other in vivo studies confirmed metal nanomaterials including QD are taken up by LC and 
subsequently transported to lymph nodes (Jatana et al. 2017b). In vitro, associations with LC 
have been shown to be influ-enced by SiNP size and surface functionalization (Vogt et al. 
2006; Rancan et al. 2012). Smaller SiNP size has also been correlated to increased uptake, 
ROS production, and cytotoxicity to LC in vitro (Nabeshi et al. 2010; Yoshida et al. 2014).
A specific observation regarding DC that has implications for ACD and dermal sensitization 
is that some metal nanomaterials can promote DC cross-presentation. Cross-presentation 
describes uptake of exogenous antigens and their subsequent processing by pathways 
normally associated with endogenous antigens. As a result, the exogenous antigen is 
presented by MHC I molecules to CD8+ T-cells, generating the cytotoxic effector cells 
characteristic of ACD.
Aluminum nanoparticles (AlNP), AuNP, FeNP, and SiNP have all been shown to modify DC 
antigen cross-presentation capacity (Blank et al. 2011; Li et al. 2011; Hirai et al. 2012; 
Jiménez-Periáñez et al. 2013; Kang S et al. 2017; Mou et al. 2017; Dong et al. 2018). The 
mecha-nism of antigen uptake by DC is known to influence the preferential association of 
antigens with MHC I or II molecules. Small lipophilic haptens associated with skin 
sensitization often enter APC via passive diffusion and bind cytoplasmic proteins, favoring 
their processing by endogenous pathways and presentation by MHC I molecules 
(Rustemeyer et al. 2006). Accordingly, passive diffusion through cell membranes similar to 
that demonstrated by charged 15 nm AuNP may result in promotion of cross-presentation 
(Arvizo et al. 2010; Lin et al. 2010; Taylor et al. 2010). Contrarily, receptor-mediated 
endocytosis of larger antigens has been associated with cross-presentation when uptake 
occurs by Fc and mannose receptors (Blum et al. 2013). In this regard, the adsorption of 
macromolecules, including immunoglobulins, to the surface of nanomaterials and 
physicochemical properties associated with the adsorption of proteins may be critically 
influential in determining the route of antigen processing.
Another major determinant of antigen association with MHC I or II is persistence inside DC. 
Antigens resistant to degradation in endosomes are more likely to be processed by MHC I 
pathways (Lin et al. 2008; Humeniuk et al. 2017). Likewise, metal nanomaterials with 
physicochemical properties capable of compromising lysosomal acidification (dissolution 
rate, surface reactivity) may promote cross-presentation (Accapezzato et al. 2005; Savina et 
al. 2006). Similarly, endosomal escape following uptake by DC can result in binding to 
cytosolic proteins and subsequent perception as an endogenous antigen (Lin et al. 2008). 
One major mechanism of endosomal antigen release leading to cross-presentation is 
oxidative stress and lipid peroxidation, causing antigen leakage from compromised 
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endosome membranes (Shen H et al. 2006; Shahbazi et al. 2014; Dingjan et al. 2016). 
Oxidative stress induced by CuNP, FeNP, and TiO2 NP have been shown to cause lipid 
peroxidation, and these metal nanomaterials have also been associated with enhancing DC 
cross-presentation (Shukla et al. 2011; Napierska et al. 2012; Manke et al. 2013). Metal 
nanomaterials have also been associated with the induction of autophagy and production of 
exosomes by DC, both of which have also been associated with antigen cross-presentation 
(Moron et al. 2004; Chaput et al. 2006; Crotzer and Blum 2009; Li et al. 2011; Shen T et al. 
2018).
Augmentation of existing or developing skin allergy
Since dermal exposure to metal nanomaterials nearly always occurs simultaneously to other 
exposures, their potential to augment skin allergy has been investigated using various allergy 
models. Metal nanomaterial effects on skin allergy have been studied with respect to both T-
cell-mediated ACD and IgE-mediated atopic dermatitis. The effects of metal nanomaterials 
in ACD models have demonstrated findings suggestive of potential effects during both 
allergic sensitization and elicitation. In one study, subcutaneous exposure to TiO2NP 1 hr 
prior to skin sensitization with dinitrochlorobenzene (DNCB) increased susceptibility of 
mice to sensitization, as evidenced by a lower concentration of DNCB required to induce 
sensitization (Hussain et al. 2012; Smulders et al. 2015). The authors noted that although 
DNCB is known to induce a TH1-dominant response characteristic of ACD, exposure to 
TiO2NP resulted in a TH2-dominant response in the regional lymph nodes. In a similar 
study, TiO2NP were applied topically 1 day prior to sensitization with DNCB, and the same 
effect on sensitization as observed (Smulders et al. 2015). A diminished TH1 response was 
observed and TiO2NP were detectable in the lymph nodes. Contrarily, SiO2NP and AgNP 
did not induce alterations to DNCB sensitizer potency in the same model.
In another study by (Jatana 2017a), a panel of metal nanomaterials with various 
physicochemical properties was analyzed for effects on chemical-induced ACD both during 
sensitization and challenge. When mice were sensitized to dinitrofluorobenzene (DNFB), 
co-administration of QD did not impact the severity of the challenge response to DNFB, 
irrespective of particle charge. However, QD administration simultaneous to DNFB 
challenge did impact the allergic response. Moreover, the effect was dependent on the charge 
of the materials. The negatively-charged particles suppressed inflammation, whereas the 
positively-charged materials enhanced ear swelling. The authors confirmed that sensitization 
to QD did not occur and suggested that variations in skin penetrating capacity of the 
differently-charged materials was responsible for the observed effects. The conclusions 
regarding a critical role for nanomaterial size and charge on modulation of ACD elicitation 
responses is supported by other findings, as well. Suppressive effects on allergic elicitation 
have also been demonstrated following applica-tion of 20 nm SiNP and <50 nm AgNP-
containing cream on ACD reactions to DNFB and 2-deoxyurushiol (Jatana 2017a). 
Contrarily, exposure to positively-charged functionalized 56 nm SiNP did not augment the 
severity of oxazolone-induced elicitation responses when topically applied for five 
consecutive days (Ostrowski et al. 2014).
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As highlighted by (Jatana 2017a), ACD responses may be subject to modulation as a result 
of chemical modifications induced by interactions with metal nanomaterials. In their study, 
the topical application of nanomaterials was subject to removal prior to application of 
DNFB. As a result, the particle-specific modulation of allergic skin inflammation was not 
reflective of blocked adduct formation. Although metal nanomaterials exhibit 
characteristically increased surface reactivity and catalytic potential, their capacity to impact 
the chemical properties of skin sensitizing chemicals has not been extensively studied. 
However, a few studies have demonstrated the potential for such effects to impact both ACD 
sensitization and elicitation. AlNP and AuNP have been shown to act as non-protein carriers 
of haptens capable of facilitating the generation of hapten-specific adaptive immune 
responses in vivo (Ishii et al. 2008; Maquieira et al. 2012). Similarly, topical application of 
ointment containing calcium-based nanoparticles has been shown to capture nickel ions by 
cation exchange, compromising bioavailability and subsequently preventing the elicitation of 
nickel-specific ACD (Vemula et al. 2011).
In addition to ACD, metal nanomaterial effects on IgE-mediated atopic dermatitis have also 
been examined. Atopic dermatitis is generally associated with protein allergens, which under 
normal circumstances are not capable of penetrating the skin (Smith Pease et al. 2002). 
However, 100 nm ZnO NP and 5 nm AuNP have been shown to enhance skin penetration by 
albumin and protein drugs (Huang et al. 2010; Shokri and Javar 2015). Likewise, increased 
permeability of the skin associated with some metal nanomaterials may represent a 
mechanism by which exposure may increase susceptibility to atopic dermatitis onset.
Simultaneous exposure to TiO2 NP, AgNP, and SiO2 NP during sensitization to house dust 
mite (HDM) in atopic dermatitis models has been associated with an amplification of TH2 
responses. This effect was shown to be more pronounced with decreasing size with respect 
to AgNP and SiO2 NP, but not for TiO2 NP (Yanagisawa et al. 2009; Hirai et al. 2012b; Hirai 
et al. 2015). Exposure to 5 nm AgNP during sensitization was associated with an 
augmentation of mast cell activity that resulted in more severe skin lesions that appeared 
earlier than those induced by 100 nm AgNP (Kang H et al. 2017). Decreases in SiO2NP size 
were also associated with enhanced TH2 responses, as evidenced by increased thymic 
stromal lymphopoeitin (TSLP) and IL-18 production (Hirai et al. 2012b). Decreased particle 
size has been associated with increased aggravation of atopic dermatitis skin inflammation 
by nonmetal nanoparticles, as well (Yanagisawa et al. 2010).
Metal nanomaterial-induced modulation of allergic inflammation in the challenge phase of 
atopic dermatitis has also been demonstrated. Topical application of both 240 and 20 nm 
ZnO NP resulted in diminished localized inflammation. However, the smaller particle was 
associated with more pronounced suppression of local inflammation, but simultaneous 
increases in systemic production of IgE (Ilves et al. 2014).
An interesting observation by Hirai et al. (2015) highlights a potentially critical variation 
between studies that may explain discordant immune effects induced by similar 
nanomaterials. distinction between allergy model studies that may contribute to discordant 
findings. The authors demonstrated that, in their study, exacerbation of allergic sensitization 
was dependent on co-administration of HDM antigen and SiO2 NP. When SiO2 NP 
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agglomerates were administered at a site distal to that of the allergen, the modulation of 
antibody production was no longer observed. The dependence of physical associations 
between nanomaterial and antigen on the subsequent adaptive immune response has been 
similarly demonstrated by FeNP. In multiple studies, intravenous administration of 58 nm 
FeNP 1 h prior to subcutaneous ovalbumin (OVA) sensitization resulted in decreased levels 
of IgG1 and IgG2 and suppression of TH1 and TH17 responses in mice (Shen et al. 2011, 
2012; Hsiao et al. 2018). Contrarily, when FeNP and OVA were co-administered 
intravenously or subcutaneously, enhanced antibody responses were seen in mice (Powles et 
al. 2017; Shen I et al. 2018). Similar immune-stimulating effects of FeNP have been 
demonstrated when used as an adjuvant by various exposure routes during immunization to 
various other antigens in the context of vaccine studies (Pusic et al. 2013; Hoang et al. 2015; 
Sungsuwan et al. 2015; Neto et al. 2018; Zhao et al. 2018).
The capacity for the same metal nanomaterial to induce divergent immune effects depending 
on its physical association with antigen likely reflect the different mechanisms of immune 
modulation associated with prototypical vaccine adjuvants. Some adjuvants exert effects 
based on “immune modulating” mechanisms. These adjuvants often bear structural 
resemblance to PAMP, which emphasizes their similar mechanisms of innate immune 
activation that promote antigen-specific adaptive responses. Since these adjuvants alter the 
systemic immune environment, their effects are not dependent on physical association with 
the antigen (Singh and O’Hagan 2003). Contrarily, physical association with antigen is 
required for adjuvants whose efficacy reflects their capacity to modulate antigen delivery to 
the immune system. The strength and nature of the adaptive immune response are heavily 
dependent on the dose and duration of antigen exposure to lymphocytes, so many adjuvants 
enhance adaptive immune responses by augmenting this process (Johansen et al. 2008).
In accordance with these two divergent mechanisms of sensitization adjuvancy, different 
physicochemical properties of metal nanomaterials may be implicated in immune effects 
resulting from each mode of action. For example, simultaneous administration of adjuvant 
and antigen is often implemented with the intent of depot formation, which increases local 
antigen retention (Glenny et al. 1931; Demento et al. 2012). Accordingly, metal 
nanomaterial adjuvant effects dependent on this mechanism are subject to influence by 
properties involved in antigen trapping, such as size, degree of agglomeration, surface area, 
and surface charge (Henriksen-Lacey et al. 2010a; Henriksen-Lacey et al. 2010b; Kaur et al. 
2012a, 2012b).
Knowledge gaps in metal nanomaterial effects on skin allergy
Knowledge regarding metal nanomaterial effects on skin sensitization is largely limited to 
TiO2 NP, SiO2 NP, and ZnO NP. Though the selective investigation of these metals is likely 
reflective of their significance to consumer skin exposures, titanium, silver, and zinc are not 
historically associated with clinically-significant rates of ACD in the general population. 
Accordingly, the observation that some of these metals may have increased potential to 
induce skin sensitization in nanoparticulate form raises additional concerns over the lack of 
investigations into nanomaterials comprised of metals commonly associated with ACD 
(nickel, gold, cobalt).
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Metal-based nanomaterials and asthma
Respiratory exposure to nanomaterials from naturally-occurring and anthropogenic sources 
has been taking place for centuries; however, the emergence of engineered nanomaterials 
and their widespread incorporation into consumer goods pose a risk for inhalation exposures 
to higher doses of materials with diverse chemical compositions and unique properties 
(Buzea et al. 2007). In this regard, metal nanomaterials of concern for consumers include 
many of the materials mentioned above, such as ZnO NP, AgNP, TiO2 NP, and SiO2 NP, as a 
result of their incorporation into construction materials, sunscreen sprays, disinfectants, and 
cosmetic powders, which upon use can lead to their inhalation. Workers are at risk for 
inhalation exposure to these and other highly-produced metal-based nanomaterials (Table 1) 
(Nanomaterials Future Markets 2015). Effects of metal nanomaterials on pulmonary 
immunity and asthmatic conditions have been extensively studied and summarized in this 
section. In addition to studies reporting adverse immune effects in workers subject to metal 
nanomaterial inhalation, animal studies that have generated evidence of potential for 
respiratory sensitization and augmentation of asthmatic conditions are discussed. Likewise, 
Table 5 summarizes studies characterizing individual metal nanomaterial effects on 
pulmonary immunity. Table 6 summarizes studies to examine the effects of metal 
nanomaterial physicochemical properties on asthma. Table 7 highlights some processes 
involved in respiratory sensitization and elicitation demonstrated to be subject to modulation 
by metal nanomaterials.
Human studies demonstrating pulmonary immune effects of metal nanomaterials
A 2014 case study best illustrates the concerns associated with the unknown allergic effects 
of metal nanomaterials. In the report, a chemist who accidentally inhaled NiNP in the work-
place subsequently developed clinical symptoms indicative of IgE-mediated respiratory 
allergy including throat irritation, nasal congestion, facial flushing, and respiratory distress 
upon future encounters with NiNP. The chemist also developed previously-nonexistent 
symptoms indicative of T-cell-mediated ACD in response to non-nanoparticulate forms of 
nickel in her earrings and belt buckles (Journeay and Goldman 2014). In addition to 
reinforcing existing concerns over increased potential for allergic sensitization as a result of 
decreased size, the case also emphasized additional concerns reflective of the unique 
mechanisms of metal allergy. The case showed that sensitization via one exposure route may 
not limit future elicitation reactions to the same tissue; moreover, sensitization by metal ions, 
irrespective of original parent material size, may result in elicitation reactions following 
exposure to both nano- and bulk-sized metal materials.
Adverse immune effects with implications for allergy have been investigated in human 
subjects with risk of inhalation exposure to metal nanomaterials in their workplaces. In one 
study, it was shown that workers of nanomaterial-handling facilities in Taiwan exhibited 
increased prevalence of sneezing, dry cough, and productive cough compared to workers 
with no nanomaterial exposures (Liao et al. 2014). Although the workers were employed by 
facilities handling SiO2 NP, Fe2O3 NP, AuNP, AgNP, and TiO2NP, it is unclear whether the 
observed respiratory effects were mediated by adaptive immune responses specific to the 
metals, or nonspecific irritant mechanisms. Interestingly, increased rates of ACD were also 
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observed in the workers of the nanomaterial-handling facilities, but the inciting agents were 
not determined. As such, it is unknown if exposure to the nanomaterials induced 
sensitization or caused increased susceptibility to ACD development in workers.
Similar studies have also demonstrated that exposure to nanomaterials in the workplace can 
cause elevations in various immune-related biomarkers indicative of potential effects on 
allergy (Andujar et al. 2014; Glass et al. 2017; Kurjane et al. 2017) For example, elevations 
in breath condensate leukotriene (LT) levels were observed in subjects exposed to TiO2 NP 
aerosol (< 100 nm) in their workplaces (Daniela et al. 2016). The exposed workers had 
elevated levels of LTB4, a lipid mediator associated with the recruitment, activation, and 
prolongation of survival of leukocytes in the lung, as well as multiple cysteinyl leukotrienes 
(i.e. LTC4, LTE4, LTD4), that are potent mediators of bronchoconstriction (Luster and Tager 
2004; Zakharov et al. 2016). Although no alterations in lung function were observed in the 
exposed workers, elevations in levels of lipid mediators involved in the pathogenesis of 
asthma suggest the potential for exposure to TiO2NP in the workplace to influence the 
severity of asthmatic conditions.
Collectively, these reports emphasize the potential occupational hazards associated with 
metal nanomaterials. Although numerous immune markers have been shown to be 
modulated in workers following inhalation exposure to metal nanomaterials, specific 
implications for asthma remain unclear. Limitations of human studies arise from 
inconsistencies between exposure conditions, subject histories, and the requirement for 
noninvasive, measurable endpoints. Accordingly, the effects of metal nanomaterials on 
pulmonary immunity and underlying mechanisms have been assessed in animal models 
wherein controlled dosing, consistent environments, and additional endpoints have helped 
identify some of the potential underlying mechanisms of metal nanomaterial-induced 
pulmonary immune effects.
Evidence for increased potential for respiratory sensitization from animal studies
Assessment of respiratory sensitization presents numerous challenges underscored by the 
absence of validated in vivo, in vitro, or in silico approaches for identification of potential 
sensitizers. However, biomarkers with proposed utility for in vivo identification of potential 
respiratory sensitizers following pulmonary exposure include IgE and TH2 cytokines (de 
Jong et al. 2009; Chary et al. 2018). These markers have not been employed for direct 
evaluation of respiratory sensitization potential by metal nanomaterials; however, numerous 
studies have reported increased IgE levels following in vivo pulmonary exposure to TiO2 NP, 
PtNP, FeNP, AgNP, and ZnO NP (Park et al. 2009; Park et al. 2010; Cho et al. 2011; Huang 
et al. 2015; Seiffert et al. 2015). Many of the same nanomaterials have also been associated 
with increased TH2 cytokine levels (i.e. IL-4, IL-5, IL-13) following pulmonary exposure 
(Pettibone et al. 2008; Park 2010; Marzaioli et al. 2014). Although these findings are 
suggestive of the potential for metal nanomaterials to induce asthma, since the specificity of 
IgE molecules was not determined in any studies, the capacity for respiratory sensitization 
remains speculative.
Assessment of respiratory sensitization potential is further complicated by the absence of an 
AOP specific to the events associated with asthma development. Moreover, discrepancies in 
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some key events involved in asthma inception by LMW and HMW agents indicate the 
potential requirement for multiple respiratory sensitization AOP. However, many steps are 
known to be conserved with respect to sensitization of the skin and lungs; knowledge of 
metal nanomaterial effects on these processes can provide potential insight regarding their 
potential to cause asthma.
The induction of respiratory sensitization is ultimately dependent on antigen bioavailability. 
Although it remains unclear whether nano-scale dimensions of metals increase the 
likelihood for absorption following dermal exposures, the respiratory tract presents a portal 
of entry known to be increasingly susceptible to smaller materials (Mercer et al. 2018). 
Nano-materials exhibit a characteristically increased level of “dustiness,” a property which 
describes the propensity for a material to become airborne following disruption (Evans et al. 
2013). Accordingly, the potential for aerosolization and inhalation of metal nanoparticles 
increases with decreasing size, thereby overcoming one of the limiting steps of respiratory 
sensitization associated with larger-sized metal particles.
Sensitization of the lungs also requires interactions between the sensitizing agent and APC. 
The respiratory tract is equipped with an expansive repertoire of defense mechanisms that 
prevent such interactions, but metal nanomaterials have been shown to have increased 
capacity to circumvent many of these mechanisms, increasing their potential for uptake by 
DC. In the upper airways, a layer of mucus lining the lumen functions to trap inhaled 
antigens and facilitate their translocation out of the trachea by the mucociliary escalator 
(Moldoveanu et al. 2009). Evasion of the ~5 mm thick mucus layer has been associated with 
nanomaterial physicochemical properties including size, surface modification, and surface 
charge (Samet and Cheng 1994; Yang et al. 2008; Liu et al. 2015; Murgia et al. 2016). 
Generally, hydrophilic, neutrally-charged nanomaterials with smaller diameters have been 
shown to penetrate mucus to a greater degree than counterparts with opposing properties 
(Schuster et al. 2013).
In the lower airways, a similar mechanism of antigen neutralization is facilitated by 
pulmonary surfactant (Chroneos et al. 2010). In addition to optimizing the mechanics of 
respiration, surfactant contains proteins capable of binding aeroallergens, accelerating their 
clearance, and preventing their uptake by APC, thereby inhibiting antigen-specific responses 
(Malhotra et al. 1993; Wang et al. 1996; Hohlfeld 2002; Ruge et al. 2011). Two of these 
proteins, surfactant protein (SP)-A and SP-D, have been shown to bind to various metal 
nanomaterials leading to accelerated clearance by phagocytic mechanisms (Ruge et al. 
2011). Accordingly, nanomaterials with properties that deter binding to surfactant proteins, 
such as surface charge, may exhibit increased potential for evasion of clearance by this 
mechanism, increasing potential for interaction with lung DC (Schulze et al. 2011).
Increased potential for antigen/nanomaterial interaction with DC can also result from 
evasion of pulmonary macrophage-mediated clearance. Uptake and sequestration of antigen 
by pulmonary macrophages results in intracellular chemical degradation or physical 
translocation out of the lungs, preventing their interception by DC (Elder and Oberdörster 
2006). Nano-materials can evade clearance by this mechanism by numerous effects. First, 
since macrophages have been shown to selectively phagocytose nanomaterials according to 
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size, charge, and surface modification, physicochemical properties may contribute to their 
persistence in the respiratory tract. Their clearance may also be compromised as a result of 
selective cytotoxic effects on pulmonary macrophages and subsequently fewer viable 
macrophages capable of neutralizing the nanoparticles. Pulmonary macrophage cytotoxicity 
has been associated with physicochemical properties including morphology, surface charge, 
and rate of dissolution (Oh et al. 2010; Hamilton et al. 2014; Shim et al. 2017). Metal 
nanomaterial-induced alterations in phagocytic activity of pulmonary macrophages, as 
demonstrated by TiO2 NP, ZnO NP, and AlNP, may also contribute to evasion of clearance 
(Wagner et al. 2007; Liu et al. 2010; Liu H et al. 2013). In addition to compromising the 
clearance capacity of the phagocytic system on a cellular level, nanomaterials are also 
associated with maximizing the clearance capacity of the collective phagocytic system. 
Volumetric loading of alveolar macrophages following inhalation of nanomaterials decreases 
the efficiency of clearance, extending biopersistence, and increasing the potential for 
interception by DC (Oberdorster et al. 1992; Blank et al. 2017).
Metal nanomaterial cytotoxic effects on pulmonary macrophages may also promote 
sensitization by additional mechanisms. Since alveolar macrophages are known to 
antagonize TH2 responses in the lung and downregulate APC functions, cytotoxic effects 
may disrupt the maintenance of an immunological tolerant state (Tang et al. 2001). 
Moreover, their depletion leads to significantly increased recruitment of DC and DC 
precursors to the lungs (Holt et al. 1993; Jakubzick et al. 2006). Numerous metal 
nanomaterials are also known to trigger the release of alarmins including IL-1β and −1α by 
alveolar macrophages; in turn, these can activate DC and facilitate sensitization (Braydich-
Stolle et al. 2010; Scherbart et al. 2011; Sandberg et al. 2012; Hamilton et al. 2014; Rabolli 
et al. 2014; Arai et al. 2015).
Similar to their roles in the development of skin allergy, epithelial cells of the respiratory 
tract are integral in the development of asthma, and their disruption by inhaled materials can 
have profound influence on the early events of sensitization (Bergamaschi et al. 2006). A 
major function of airway epithelial cells is to serve as a physical barrier between inhaled 
agents that deposit in the airway lumen and DC in the epithelium (Hammad and Lambrecht 
2015). The importance of barrier integrity in preventing the development of asthma is 
illustrated by the barrier-disrupting proteolytic activity shared by many aeroallergens with 
high rates of sensitivity in the population (Kauffman et al. 2006; Lambrecht and Hammad 
2012). The frequent observation that metal nanomaterials are capable of inducing 
cytotoxicity to pulmonary epithelial cells suggests their potential to increase permeability 
and passage of antigens from the airway lumen to compartments associated with DC.
Airway epithelial cell cytotoxicity has also been associated with the release of alarmins that 
have potential to promote DC activation and sensitization. Similar to keratinocytes in the 
skin, the mechanism of cell death can critically influence the nature of the resultant immune 
response. For example, the necrotic cell death following pulmonary exposure to beryllium 
results in the release of mediators including cellular DNA, which is recognized as a DAMP 
by TLR-9, and promotes the unique TH1-mediated effects associated with chronic beryllium 
disease (McKee et al. 2015). NiNP, AgNP, and CoNP have been shown to induce similar 
necrotic cell death of bronchial and alveolar epithelial cells (Holt et al. 1993; von Garnier et 
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al. 2005; de Haar et al. 2008; Capasso et al. 2014; Ortega et al. 2014). Contrarily, ZnO NP, 
CuO NP, TiO2 NP, and CrNP have all been associated with induction of apoptotic cell death 
in pulmonary epithelial cells (Park et al. 2007, 2008; Ahamed et al. 2011; Sun et al. 2012; 
Senapati et al. 2015). This effect may further influence the development of respiratory 
allergy since uptake of these cells is a property exclusive to CD103+ DC, a subset of DC 
associated with cross-presentation and the subsequent induction of CD8+effector responses 
(Desch et al. 2011).
Incorporation of metal nanomaterials into asthma models
The impact of metal nano-material exposure prior to sensitization has only been addressed 
by a few studies using asthma models. Aspiration exposure to ZnO NP, TiO2 NP, NiO NP, 
CuO NP, or SiO2 NP 1 d before inhalation sensitization to OVA was followed by inhalation 
challenge and subsequent assessment of asthmatic severity. Soluble metal nanomaterials 
(NiO NP, ZnO NP, and CuO NP) were associated with elevations in OVA-specific IgE, 
whereas insoluble SiO2 NP and TiO2 NP were not. Subsequent investigations confirmed the 
importance of metal ion release in the adjuvant effects on sensitization. The increase in 
OVA-specific IgE production associated with soluble NiO NP was not conserved in response 
to insoluble NiO microparticles in the same model (Horie et al. 2015). However, ZnCl2 also 
did not exert the same increase in OVA-specific IgE caused by ZnO NP. As a result, it was 
concluded that continuous ion release from nanoparticles was required for the induction of 
the observed effects (Horie et al. 2016). Exposure to residual oil fly ash particles prior to 
allergen sensitization has also been associated with adjuvant effects attributable to soluble 
metal constituents (Lambert et al. 2000).
Concurrent exposure to metal nanomaterials during allergen sensitization has been explored 
extensively in order to evaluate the potential adjuvant effects of metal nanomaterials on 
asthma development. This concept has been explored with respect to both systemic and 
respiratory sensitization routes, as well as independent and dependent of allergen challenge. 
In the absence of allergen challenge, evaluation of sensitization achieved by intraperitoneal 
injection is limited to assessment by systemic markers, such as antigen-specific IgE and 
cytokine levels. Accordingly, co-administration of AgNP and ZnO NP with antigen has been 
associated with elevated levels of allergen-specific IgE, as well as increased levels of TH2 
cytokines (Matsumura et al. 2010; Xu et al. 2013). As demonstrated with SiO2 NP, enhanced 
antibody production has been associated with both increasing dose and decreasing particle 
size (Toda and Yoshino 2016).
Though few studies have correlated metal nanomaterial properties to adjuvant effects on 
intraperitoneal sensitization independent of allergen challenge, existing findings are 
conducive with studies using larger metal particles and nonmetal nanoparticles (Naim et al. 
1997; Granum 2001b). The impact of the most extensive number of physicochemical 
properties with respect to adjuvant effects on OVA sensitization use polystyrene 
nanoparticles (PSP). Nygaard et al. (2004) used PSP ranging from 58 nm to 11.4 μm to 
evaluate the influence of particle size, mass, surface area, and particle number. Similarly, 
Granum et al. (2000) used six sizes of spherical PSP to administer doses with constant mass 
(12.25 μg), size (0.1 μm), particle number (8 × 1010), or surface area (1300 cm2). Both 
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studies showed that serum OVA-specific IgE levels best correlated with particle number and 
surface area (Granum et al. 2001a; Nygaard et al. 2004).
Similar adjuvant effects have been observed following respiratory sensitization and co-
exposure to TiO2 NP, SiO2 NP, and ZnO NP (de Haar et al. 2006; Huang et al. 2015). 
Increases in OVA-specific IgE and TH2 cytokine levels were similarly associated with 
decreasing size of SiO2 NP (Yoshida et al. 2011). Moreover, SiO2NP surface properties were 
shown to impact sensitization independent of allergen challenge. Intranasal exposure to three 
variations of SiO2 NP (spherical, mesoporous, and PEGylated) simultaneous to OVA 
sensitization exacerbated pathological changes, inflammatory cell influx, and TH2 cytokine 
responses. These effects were specific to the unique surface chemistry of each type of SiO2 
NP, but the most severe responses were associated with the nanoparticle with the highest 
surface area (Han et al. 2016).
The absence of allergen challenge in these studies helps elucidate the direct effects of metal 
nanomaterials on sensitization processes. However, another approach to evaluate the same 
effect involves evaluation of allergic parameters collected in response to allergen challenge. 
Studies utilizing this approach have similarly demonstrated enhanced asthmatic responses in 
OVA-challenged mice when intraperitoneal sensitization occurred simultaneous to TiO2 NP 
and ZnO NP (Larsen et al. 2010; Roy et al. 2014a; Roy et al. 2014b; Mishra et al. 2016).
Although the observed effects may reflect residual impacts of metal nanomaterial respiratory 
exposure during sensitization, similar adjuvant effects on elicitation responses have been 
observed following respiratory sensitization and simultaneous metal nanomaterial exposure. 
Simultaneous administration of SiO2NP, CeO2NP, QD, and TiO2NP with allergen during 
sensitization led to enhanced asthmatic response severity, as measured by antigen-specific 
antibody levels, inflammatory cell influx, and TH2 cytokine levels after challenge 
(Brandenberger et al. 2013; Meldrum et al. 2018; Vandebriel et al. 2018; Scoville et al. 
2019). Studies using similar sensitization procedures and endpoints have also implicated 
TiO2 NP crystal structure in adjuvant effects on sensitization (de Haar et al. 2006; 
Vandebriel et al. 2018).
Metal nanomaterial exposure has also been incorporated into the challenge phase of asthma 
to evaluate potential modulation of asthmatic responses in established asthmatic conditions. 
Although some metals, including CuO NP, have been exclusively shown to induce 
significant aggravating effects on elicitation responses, others, including AuNP, appear to 
exert protective effects on asthmatic responses (Barreto et al. 2015; Park et al. 2016; Omlor 
et al. 2017). Contrarily, other metal nanomaterials, including TiO2 NP, have been associated 
with divergent effects on allergen challenge that appear increasingly susceptible to variation 
during this phase of asthma. Effects have been reported to be differentially induced 
according to dose, duration of exposure, and endpoints of assessment (Rossi et al. 2010; 
Hussain et al. 2011; Jonasson et al. 2013; Kim et al. 2017).
Similarly, after OVA sensitization via intraperitoneal injection, AgNP exposure during 
allergen challenge has been reported to induce various aggravating and attenuating effects on 
allergic inflammation. Inhalation exposure to 6 nm AgNP was shown in multiple studies to 
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suppress inflammatory cell influx, airway hyper-reactivity (AHR), mucus hypersecretion, 
and other measures of asthmatic responses (Park, Kim, Jang, et al. 2010; Jang et al. 2012). 
Contrarily, in another study with very similar exposure conditions, 33 nm AgNP caused 
increased airway response, inflammatory cell influx, and OVA-IgE levels over control 
animals (Chuang et al. 2013; Su et al. 2013). The discrepancies between these studies may 
be attributable to AgNP size difference, as well as potential variations in particle coating, 
both of which have been associated with differ-ential effects on asthmatic responses 
(Alessandrini et al. 2017). Additionally, the first two studies used the TH1-dominant 
C57BL/6 mouse strain, whereas the second used a TH2-biased BALB/c strain (Jones et al. 
2013). Strain-specific immune responses following respiratory exposure to metal 
nanomaterials during allergen challenge have been demonstrated in other studies, as well 
(Gustafsson et al. 2014).
Studies using SiNP and ZrO NP with variations in surface properties demonstrate that when 
administered during allergen challenge, surface properties of nanomaterials can differen-
tially aggravate allergic inflammation (Marzaioli et al. 2014; Park, Sohn, et al. 2015; 
Vennemann et al. 2017). It has been suggested that particles with higher oxidant potential 
amplify asthmatic inflammation to a greater degree, which would implicate physicochemical 
properties such as surface modification in these effects (Li et al. 2009).
Potential mechanisms of asthma augmentation by metal nanomaterials
Although asthma models have characterized the potential effects of metal nanomaterial 
exposure on asthmatic processes, many of the underlying mechanisms of these observed 
effects remain unclear. However, findings from other studies suggest several mechanisms 
may be associated with the observed effects of metal nanomaterials on the augmentation of 
asthma.
Respiratory exposure to metal nanomaterials may increase susceptibility to sensitization by 
aeroallergens by similar mechanisms previously proposed to contribute to their respiratory 
sensitization potential. Release of alarmins by airway epithelial cells and resident immune 
cells, disruption of the TH1/TH2 balance in the lung, and amplification of oxidative stress by 
metal nanomaterials may also generate adjuvant effects on sensitization. Similarly, FeNP, 
TiO2 NP, and SiNP have all been shown induce the release of TH2 cytokines including 
IL-33, TSLP, GM-CSF, and IL-25 by airway epithelial cells, which are known to promote 
DC maturation (Hussain et al. 2009; Val et al. 2009; Mano et al. 2013; Park, Sohn, et al. 
2015).
Evidence also suggests metal nanomaterial exposure can modulate inflammatory pheno-
types of existing asthmatic conditions. Two major heterogeneous asthma phenotypes differ 
based on the presence of neutrophil (TH1/TH17)- or eosinophil (TH2)-dominated 
inflammation (Fahy 2009; Yu and Chen 2018). Particulate and soluble metals are known to 
differentially impact the nature of existing allergic airway inflammation by skewing this 
balance (Schneider et al. 2012). Dissolution kinetics also appear influential in this regard, as 
CoNP, NiNP, ZnO NP, and CuO NP and their corresponding ions have been shown to 
differentially recruit eosinophils and neutrophils to the lungs of rats after exposure (Cho et 
al. 2011; Jeong et al. 2015).
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Modulation of elicitation response severity by metal nanomaterials may emerge as a result of 
modulation of mast cell activity. As a major effector cell in IgE-mediated allergic responses, 
mast cells have been shown to be potential targets of metal nanomaterial-induced adverse 
effects in vitro (Feltis et al. 2015; Johnson et al. 2017; Alsaleh and Brown 2018). AgNP, 
CuO NP, SiO2 NP, and TiO2 NP have all been shown to induce IgE-independent mast cell 
degranulation depending on physicochemical properties including size, surface area, charge, 
shape, and the presence of adsorbed surface proteins (Marquis et al. 2011; Aldossari et al. 
2015; Alsaleh et al. 2016; Johnson et al. 2017). Modulation of IgE-dependent mast cell 
degranulation has also been demonstrated by some of the same nanomaterials. TiO2 NP, 
AuNP, CeO2 NP, ZnO NP, and FeNP have been shown to modulate interactions between 
allergen and surface-bound IgE molecules, interfering with dimerization and subsequent 
degranulation (Huang et al. 2009; Ortega et al. 2015). Similarly, mast cell uptake of metal 
nanomaterials has been associated with modulation of intracellular calcium signaling 
involved in mast cell degranulation (Amin 2012; Chen et al. 2012). Accordingly, differential 
ion release by bulk ZnO particles, ZnO NP, and soluble ZnSO4 has been correlated with the 
propensity for OVA-sensitized rat mast cells to degranulate when co-exposed with OVA 
(Yamaki and Yoshino 2009; Feltis et al. 2015).
Furthermore, TiO2 NP and AuNP have been shown to alter the exocytic kinetics of granule 
secretion by mast cells (Marquis et al. 2009). The qualitative and quantitative profile of 
granule contents has also been shown to be subject to modulation by some metal 
nanomaterials. The number of molecules per granule has been shown to be impacted by 
SiO2 NP as a function of porosity and surface area (Maurer-Jones et al. 2010). Variations in 
vesicle mediator content has been shown to be augmented by AuNP (Marquis et al. 2009). 
Since the contents of mast cell granules contribute to vascular permeability and 
inflammatory cell recruitment, these alterations can greatly impact the severity of allergic 
elicitation (Dudeck et al. 2011; Weber et al. 2015).
Aggravation of existing asthmatic conditions may also involve non-immunological 
mechanisms, such as metal nanomaterial-induced alterations to normal physiological 
processes. For example, increased mucus production by epithelial cells is a hallmark 
symptom of the early and late phase asthmatic response (Erle and Sheppard 2014). The 
observation that TiO2NP and CuONP both increased mucin secretion in human epithelial 
cells suggests potential to exacerbate asthmatic conditions by contributing to obstruction of 
airways (Chen et al. 2011; Park et al. 2016). Similarly, TiO2 NP, AuNP, and AgNP have 
been shown interfere with optimal pulmonary surfactant functioning, which can cause AHR 
and increased resistance to airflow (Hohlfeld et al. 1999; Hohlfeld 2002; Bakshi et al. 2008; 
Schleh et al. 2009; Zhang et al. 2018). AHR may also be modulated by metal nanomaterials 
as a result of alteration of airway smooth muscle (ASM) contractility. ZnO NP, CuO NP, and 
TiO2 NP have all been shown to alter human ASM mechanical function in vitro (Berntsen et 
al. 2010). Similarly, CoFe2O4 NP were shown to potentiate both histaminergic and 
cholinergic ASM contractility in vivo, which has the capacity to exacerbate symptoms of 
asthma associated with bronchoconstriction (Kapilevich et al. 2012).
Metal nanomaterial exposure may also exacerbate established asthmatic conditions by 
accelerating the progression of pathological alterations associated with chronic asthmatic 
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conditions. The repetitive induction and resolution of inflammation induced by asthmatic 
elicitation leads to anatomical alterations referred to as airway remodeling (Fehrenbach et al. 
2017). Histological indicators of these alterations have been reported to be exacerbated by 
various metal nanomaterials including SiNP (Han et al. 2011). Similarly, cellular indicators 
of accelerated airway remodeling have been implicated in response to many metal 
nanomaterials. For example, fibroblast accumulation and increased extracellular matrix 
deposition is a common contributor to airway remodeling and has been observed in response 
to NiNP, SiO2 NP, and CeO2 NP exposure (Warner and Knight 2008; Han et al. 2011; Ma et 
al. 2012; Armand et al. 2013; Glista-Baker et al. 2014).
Knowledge gaps in metal nanomaterial effects on asthma
Despite the known capacity for many metals to induce IgE-mediated asthma following 
inhalation, the potential for metal nanomaterials to induce sensitization of the respiratory 
tract remains completely unknown. Several other interesting aspects of pulmonary immunity 
have not been widely addressed with respect to metal nanomaterials, and may have 
relevance to current observations regarding their effects on asthma. The microbiome is 
known to significantly impact numerous aspects of allergic disorders, and while some metal 
nanomaterials associated with antimicrobial activity have been shown to alter the pulmonary 
microbiome, the implications for asthma remain unknown (Alessandrini et al. 2017; Poh et 
al. 2018). Similarly, the effects of metal nanomaterials on innate lymphoid cells also remain 
largely unstudied, but should not continue to be neglected, given the importance of this cell 
type in allergic disorders. Finally, the capacity for metal nanomaterials to disrupt or prevent 
the development of immunological tolerance has not been explored, and may be influential 
in both phases of asthmatic conditions.
Effects of metal nanomaterials on immune cells and allergic processes in 
vitro
In vivo studies have demonstrated the capacity for metal nanomaterials to augment 
numerous immunological processes that result in functional implications for allergic disease. 
However, in vitro investigations have helped elucidate some of the underlying mechanisms 
responsible for in vivo observations. In this section, major findings regarding the role of 
metal nanomaterial physicochemical properties on molecular and cellular processes with 
implications for both ACD and asthma are summarized.
Effects on antigen immunogenicity
Many physicochemical properties associated with the molecular and cellular processes that 
confer antigen immunogenicity are subject to alteration following interactions with 
constituents of their environment. In this regard, the immunogenicity of metal nanomaterials 
may be significantly altered as a result of biocorona formation. Following entry into 
biological media, macromolecules present in the media interact with and adsorb to the 
surface of nanomaterials within minutes, forming a layer that defines the bio-identity of the 
nanomaterial (Corbo et al. 2016). The qualitative profile of adsorbed constituents and 
quantitative strength of association have been shown to be influenced by nanomaterial 
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properties including size, charge, morphology, surface modification, and hydrophilicity, 
among other properties (Lundqvist et al. 2008; Dobrovolskaia et al. 2014).
Independent of adsorbed constituents’ identities, macromolecule associations with metal 
nanomaterial surfaces may induce alterations in physicochemical properties associated with 
their bioactivity (Dobrovolskai et al. 2009b; Yin et al. 2015). For example, protein 
adsorption to 25 nm FeNP was associated with a 5-fold increase in hydrodynamic size, 
which can impact a number of biological effects, such as propensity for cellular uptake 
(Calatayud et al. 2014). Similarly, adsorption of proteins can mask reactive surfaces of metal 
nanomaterials, attenuating ROS generation, and subsequently inhibiting a major biochemical 
mechanism involved in the release of alarmins (Ilinskaya and Dobrovolskaia 2016).
Contrarily, surface adsorption of macromolecules may alter the biological activity of metal 
nanomaterials in a manner that is dependent on the adsorbed constituent profile. Endo-
genous proteins, including immunoglobulins, cytokines, and complement proteins are all 
constituents of the serum and lung lining fluid known to bind metal nanomaterial surfaces 
(Neagu et al. 2017). The binding of complement protein C3b and IgG to nanomaterial 
surfaces has been shown to confer recognition by complement and Fc receptors, accelerating 
clearance by phagocytes, and limiting the potential of the nanomaterial to induce other 
immune effects (Beduneau et al. 2009; Moghimi et al. 2012; Frohlich 2015). Adsorption of 
exogenous agents can also lead to alterations in nanomaterial immunogenicity. One of the 
most notable examples is endotoxin (LPS), a frequent microbial contaminant of 
nanomaterial surfaces that is capable of activating innate immune cells, and inducing pro-
inflammatory signaling via the TLR-4 pathway. Adsorption of LPS to nanomaterial surfaces 
has been shown to enhance inflammatory responses to many metal nanomaterials by lung 
epithelial cells, and various immune cells (Shi et al. 2010; Liu et al. 2012; Bianchi et al. 
2017; Li et al. 2017; Ko et al. 2018). The chemical structure of LPS favors its adsorption to 
hydrophobic, positively-charged metal nanomaterial surfaces, indicating a role for 
physicochemical properties such as surface modification in the propensity for associations 
with immunogenic exogenous molecules such as LPS (Gorbet and Sefton 2005; Li et al. 
2017).
Although biocorona formation can augment the immunological fate of a nanomaterial, the 
interactions may also facilitate alterations in immunogenicity of the adsorbed constituents. 
Deng et al. (2010) showed that functionalized AuNP were capable of binding fibrinogen 
independent of nanoparticle size, but certain sizes of AuNP induced conformational changes 
in the protein. Subsequent alterations in protein structure conferred its recognition by the 
Mac-1 receptor, subsequently activating NF-κB signaling in innate immune cells. Similarly, 
Bastus et al. (2009) demonstrated that while macrophages did not recognize AuNP or two 
biomedically-relevant peptides individually, their conjugation facilitated recognition by 
TLR-4 and the subsequent induction of pro-inflammatory cytokine production. Since these 
signaling pathways play critical roles in many of the adjuvant effects mentioned in previous 
sections, interactions between metal nanomaterials and host proteins can generate novel 
sources of immunogenicity that may promote allergic processes.
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The generation of metal antigens in vitro has been shown to be impacted by the unique 
physicochemical properties of metal nanomaterials. The size-specific increase in surface 
energy of TiO2 NP was shown to promote associations between the metal and human serum 
albumin, resulting in increased bioavailability (Vamanu et al. 2008). This altered propensity 
for inter-actions with host proteins contributed to the observation that titanium antigens 
generated from ionic and nanoparticulate forms of TiO2 induced differential proliferation of 
CD4+ and CD8+ T-lymphocytes in vitro (Hol et al. 2018).
Effects on processes involved in sensitization
As the primary APC involved in allergic sensitization, the capacity for metal nanomaterials 
to modulate DC activity represents a prominent mechanism by which allergic sensitization 
can be impacted (Jia et al. 2018). Since many sensitizing agents are known to induce both 
antigen-specific and nonspecific signals to DC following exposure, DC activation is a step of 
the dermal sensitization AOP used for in vitro identification of potential sensitizers. 
Accordingly, the h-CLAT method has been validated for use by the OECD to determine the 
skin sensitizing potential of agents. In this assay, undiffer-entiated THP-1 human monocytic 
leukemia cells are exposed to an agent for 24 h and their activation status is subsequently 
assessed by quantification of CD86 and CD54 activation marker expression (Ashikaga et al. 
2002, 2006; Nukada et al. 2012).
The h-CLAT assay has not been employed to evaluate the sensitizing potential of any metal 
nanomaterials; however, several studies have investigated metal nanomaterial effects on 
undifferentiated THP-1 cells following a 24-h exposure, and reported activation marker 
expression. Accordingly, up-regulation of CD86 expression was observed following 
exposure to surface-modified FeNP, SiO2 NP, and mixed-metal alloy nanoparticles (Liu, Y et 
al. 2013). de Marzi et al. (2017) exposed THP-1 cells to a wide range of SiO2 particle sizes 
(10–1430 nm); while all particles promoted activation marker expression, the 240 nm SiO2 
particles induced the greatest degree of CD80 expression. Similar findings were reported by 
an investigation that assessed the potential for metal debris released from orthopedic 
implants to trigger immune activation. Both ~2 mm cobalt-chromium-molybdenum alloy 
particles and soluble metal ions induced elevations in THP-1 co-stimulatory molecule 
expression, suggesting that a wide range of metal particle sizes have the capacity to induce 
immune effects involved in allergic sensitization (Caicedo et al. 2010; de Marzi et al. 2017). 
Contrarily, no elevations in THP-1 expression of CD86 or CD54 were observed in response 
to 100 nm AgNP exposure (Galbiati et al. 2018).
Though CD86 and CD54 are the validated biomarkers indicative of sensitizing potential in 
the THP-1 line, limited reports have evaluated these specific markers following metal 
nanomaterial exposure. However, other markers indicative of DC activation, such as MHC 
II, CD11b, CD14, CCR2, and CCR5 have been reported to be up-regulated in response to 
exposures to ZnO NP and FeNP (Prach et al. 2013; Matuszak et al. 2015). Similarly, 
modulation in expression of 60 genes – several of which were correlated to monocyte 
differentiation and maturation – were observed in response to PtNP exposure (Gatto et al. 
2018).
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The THP-1 cell line has also been used to identify potential skin sensitizers in vitro based on 
a unifying property of rapid ROS production following exposure to skin sensitizing 
chemicals (Miyazawa and Takashima 2012). A similar response has been demonstrated in 
the cell line following exposure to < 100 nm silver-copper alloy nanoparticles, AgNP, CoO 
NP, PdNP, and NiNP (Monprasit et al. 2018). The degree of ROS production by THP-1 cells 
has been correlated to properties including particle size and corona presence, as well as 
exposure dose and duration (Foldbjerg et al. 2009; Casals et al. 2011; Neubauer et al. 2015). 
Subsequent activation of the p38 MAPK signaling pathway, alterations in expression of 
HMOX1 and other oxidative stress genes have also been used as in vitro biomarkers 
suggestive of sensitizing potential. Numerous metal nanomaterials have been associated with 
these effects on THP-1 cells, which suggests their potential to activate DC and promote 
sensitization (Mohamed et al. 2011; Khatri et al. 2013; McConnachie et al. 2013; 
Boonrungsiman et al. 2017).
The potential for metal nanomaterials to induce DC activation has been more extensively 
examined using primary DC than the cell lines used in the validated assays (Kang and Lim 
2012). Although the expression of activation markers in murine bone marrow-derived DC 
(BMDC) or human monocyte-derived DC (MDDC) has not been validated by OECD for use 
in determining sensitization potential in vitro, several studies have reported their capacity to 
accurately predict sensitizers (Tuschl et al. 2000; Pepin et al. 2007). Accordingly, TiO2 NP, 
ZnO NP, and SiO2 NP have been associated with increased expression of CD80 and CD86 
by murine BMDC with respect to size, surface chemistry, and crystallinity (Palom€aki et al. 
2010; Heng et al. 2011; Winter et al. 2011; Zhu et al. 2014; Winkler et al. 2017; Vandebriel 
et al. 2018).
Nanomaterial-induced modulated DC activity can also influence sensitization indepen-dent 
of their capacity to induce phenotypical maturation. For example, uptake of AuNP and 
AgNP resulted in an enhanced capacity for DC maturation in response to other immune 
stimuli (Orlowski et al. 2018). This finding suggests uptake of antigens normally incapable 
of activating DC may trigger their maturation in the presence of nanomaterials. In addition, 
accumulation of metal nanomaterials has been proposed to interfere with antigen processing 
and presentation by DC (Thiele et al. 2003; Humeniuk et al. 2017).
Polarization of DC and the subsequent preferential generation of TH1/TH2 effector T-cells is 
another step in the development of allergy that has been shown to be susceptible to 
modulation by nanomaterials. Dermal and respiratory sensitizers are associated with 
divergent oxidative stress responses that induce selective alterations in three major signaling 
pathways responsible for DC polarization (Mizuashi et al. 2005; Antonios et al. 2009). 
Polarization of DC towards TH1-promoting activity has been associated with the propensity 
for skin sensitizers to react with cytoplasmic glutathione following which, rapid depletion 
leads to ROS accumulation. The rapid induction of oxidative stress induced by contact 
sensitizers is responsible for the selective activation of the p38 MAPK and JNK signaling 
pathways within minutes of encounter (Nakahara et al. 2006). Contrarily, polarization of DC 
towards TH2-dominant responses has been associated with delayed induction of oxidative 
stress resulting from the preferential association of respiratory sensitizers with intracellular 
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amine groups (Ferreira et al. 2018). Subsequently, selective activation of the NF-κB and 
ERK pathways occurs.
Knowledge of these pathways and their differential activation explain the observation that 
metal nanomaterials with opposing catalytic properties induce different polarization profiles 
in DC in vitro. The oxidant capacity of TiO2 NP resulted in potentiation of DC maturation 
leading to a TH1-biased responses, whereas treatment with the anti-oxidant surface activity 
of CeO2 NP resulted in secretion of anti-inflammatory IL-10 and a TH2-dominant T-cell 
profile (Schanen et al. 2013). FeNP, AuNP, and GdNP have also been associated with 
modulation of DC polarization in vitro with respect to size and surface chemistry (Yang et 
al. 2010; Vallhov et al. 2012; Tomi c et al. 2014; Hoang et al. 2015).
Effects on processes involved in elicitation of allergy
Metal nanomaterials have been shown to have potential to influence elicitation reactions 
specific to both metals and environmental proteins in vitro. With respect to metal allergy, 
PBMC isolated from women with established allergic sensitivity to palladium were 
challenged with either 5–10 nm PdNP or palladium salts in vitro (Reale et al. 2011). 
Variations in TNFα and IL-10 release were noted between exposures, indicating a potential 
role for metal solubility on metal-specific allergy elicitation. With respect to environmental 
allergens, basophils isolated from patients with established sensitivity to common 
environmental allergens including birch pollen, timothy grass pollen, and house dust mite 
were exposed to AuNP-conjugated with corresponding allergenic proteins. Stable coronas 
were formed by all three allergens, but binding of allergen to AuNPs caused enhanced 
activation of basophils in response to house dust mite challenge, as well as birch pollen in 
some individuals (Radauer-Preiml et al. 2016).
Although lymphocyte cytotoxicity is an immunotoxic effect most often associated with 
immunosuppression, as major effector cells of both IgE and T-cell-mediated allergic 
responses, this effect has potential to impact allergic disorders, as well. Accordingly, many 
metal nano-materials have been shown to be cytotoxic and genotoxic to human and murine 
lymphocytes in vitro. Interestingly, T- and B-lymphocytes have been shown to be more 
resistant to adverse effects of ZnO NP compared to other immune cell types (Hanley et al. 
2009). Although ion release from ZnO NP and PdNP was correlated to cytotoxicity and 
alteration in gene expression, DNA damage induced by CoNP was shown to be more severe 
than that induced by Co ions (Jiang et al. 2012; Tuomela et al. 2013; Petrarca et al. 2014; 
Simon-Vazquez et al. 2016). Susceptibility to cytotoxicity was shown to be reflective of cell 
cycle status, explaining the finding that memory T-cells were more sensitive to metal 
nanomaterial effects compared to naïve T-cells (Hanley et al. 2009; Shahbazi et al. 2013).
Modulation of T-lymphocyte activity by metal nanomaterials also has the potential to 
significantly influence allergic processes. PdNP, AuNP, CoNP, and GdNP have all been 
shown to induce differential TH1/TH2-biased cytokine production by lymphocytes in vitro 
dependent on size, solubility, and hydrophobicity (Petrarca et al. 2006; Liu et al. 2009; 
Boscolo et al. 2010; Moyano et al. 2012). FeNP suppressed the activity of Kv1.3 channels, 
which suggests a potential mechanism of lymphocyte cell signaling modulation (Yan et al. 
2015). Additionally, delays in proliferation, altered mitogen responses, and morphological 
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changes have also been observed by lymphocytes following exposure to various metal 
nanomaterials (Shin et al. 2007; Beer et al. 2008; Liptrott et al. 2014; Devanabanda et al. 
2016).
Knowledge regarding effects of metal nanomaterials specifically on B-cells in vitro is 
limited to AuNP, which have been shown to be size-dependently taken up by B-cells, 
causing alterations in NF-κB and blimp1/pax5 signaling pathways, and altered secretion of 
immune-globulins in a size-dependent manner via (Sharma et al. 2013; Lee et al. 2014). The 
potential for metal nanomaterials to directly alter B-cell processes, such as antigen-specific 
interactions with T-cells, isotype switching, and affinity maturation, events critical to their 
effector functions in IgE-mediated allergic disorder such as asthma, remains largely 
unstudied (Luo et al. 2015).
Knowledge gaps in metal nanomaterial effects on immune cells and processes in vitro
Formation of the nanomaterial biocorona has been almost exclusively investigated with 
respect to the adsorption of proteins. However, nanomaterials are also subject to interactions 
with other macromolecules present in biological fluids, such as nucleic acids and lipids. 
Adsorption of these molecules may have notable impacts on the immune effects of 
nanomaterials since different nucleic acids are alarmins recognized by PRR and lipid 
mediators play critical roles in many aspects of allergic disorders (Schauberger et al. 2016; 
Muller et al. 2018). Accordingly, more research should be directed towards investigating the 
biological implications of surface-adsorbed macromolecules other than proteins. Similarly, it 
has been suggested that metal nanomaterials may act as soluble or particulate antigens, but 
the dynamics of metal antigen generation remains largely unstudied with respect to 
nanoparticles.
Important considerations for future metal-based nanomaterial allergy 
studies
The potential for metal-based nanomaterials to induce immune effects with implications for 
allergic disease following exposure by routes other than dermal contact or inhalation is a 
significant knowledge gap. Nanomaterials are being increasingly incorporated into foods, 
beverages, supplements, and packaging, rendering ingestion exposures an increasing 
concern (Chaudhry et al. 2008). Ingestion of metal nanomaterials has been associated with 
altered B-cell distribution, increased levels of IgE and IgG, and splenic toxicity, but the 
implications of these effects on allergy are unknown (Park et al. 2010a; Kim et al. 2014; 
Sheng et al. 2014). Similar immune effects have been observed following systemic 
administration of various metal nanomaterials. Although most current uses for metal 
nanomaterials are not likely to result in systemic exposures, some nanomaterials with 
expanding biomedical applications present a concern. The significance of this knowledge 
gap is demonstrated by the numerous adverse effects in patients administered Feraheme 
(ferumoxytol), an intravenously-administered iron replacement product containing 17–31 
nm colloidal Fe3O4NP (Lu et al. 2010). In the 5 years following approval for use by the 
Food and Drug Administration (FDA) in 2009, 79 anaphylactic reactions were reported, of 
which 19 were fatal.
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As more studies are conducted to advance our understanding of the effects of metal 
nanomaterials on allergic disease, it should be recognized that accurate assessment is 
dependent on the evaluation of sample contamination with endotoxin (Dobrovolskaia et al. 
2009a). As a result of production and handling in non-sterile conditions, engineered 
nanomaterials are often carriers of impurities including LPS, a potent immunoadjuvant 
(Smulders et al. 2012). Accordingly, the presence of endotoxin on surfaces of metal 
nanomaterials could generate a subsidiary but sufficient amount of immunostimulation 
required to induce allergic sensitization to the metal itself, or to other allergens. 
Consequently, exposure to immunologically inert metal nanomaterials contaminated with 
LPS may lead to misidentification of such agents as sensitizers or adjuvants. Many of the 
studies published prior to this development do not report the presence or absence of 
endotoxin in samples, and results should be interpreted with caution.
Another consideration for future studies is that the successful correlation of metal 
nanomaterial physicochemical properties with mechanisms of toxicity is limited by the 
accurate assessment and reporting of test material characterization. Although thorough 
material character-ization has become recognized as an indispensable step in nanotoxicity 
studies, discrepancies in property terminology, evaluation methods, property reporting, and 
the biological relevance of measured properties complicate comparisons between studies. A 
notable example of inconsistent property terminology is the tendency for non-discriminate 
reporting of aggregates and agglomerates of primary particles. The irreversible bonds of 
aggregates and reversible bonds of agglomerates can impact the effective dose surface area, 
degree of primary particle dissociation, and other properties that dictate in vivo biological 
effects (Keene and Tyner 2011; Gualtieri et al. 2012; Sharma et al. 2014). Another property 
subject to inconsistent reporting is nanomaterial surface area. Differences in the material 
state and method of assessment can generate results representative of different parameters, 
including volume-specific, geometric, or specific surface area SSA (van Doren et al. 2011; 
Wohlleben et al. 2017). Although these metrics are often similarly reported by studies, they 
have been correlated to notable variations in toxic potential (Sager et al. 2016). The use of 
multiple assessment methods and disclosure of potential sources of measurement variation 
between studies will help accurately compare the impact of properties on toxic potential in 
future studies.
Accurate evaluation of nanomaterial physicochemical properties and their correlation to 
toxic effects has become increasingly relevant as emerging nanomaterials challenge the 
efficacy of traditional occupational exposure limits (OEL). The majority of respiratory 
occupational exposure limits do not discriminate for material size, so as new metal-based 
nanomaterials emerge, they are subject to the same mass-derived values enforced for other 
materials of the same elemental composition. This issue is proving problematic as 
nanotoxicity studies continue to demonstrate that mass may not be the best dose metric for 
prediction of pulmonary toxicity (Schmid and Stoeger 2016). Moreover, as demonstrated by 
the studies summarized here, metal nanomaterial properties other than mass have been 
correlated to immune effects following respiratory exposure. Accordingly, size nonspecific 
OELs may be ineffective in protecting workers from both nanomaterial-induced pulmonary 
effects, as well as subsequent immune effects (Schulte et al. 2010). This concern has become 
increasingly recognized, as NIOSH has recommended size-specific exposure limits for TiO2. 
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Despite the recommended time-weighted average exposure limits of 2.4 mg/m3 for fine TiO2 
and 0.3 mg/m3 for ultrafine and nanoscale TiO2, the agency responsible for regulating 
compliance with its own established limits(i.e. OSHA) has not yet adopted size-specific 
OEL values for TiO2 (NIOSH 2011).
Conclusions
Although there is a growing amount of toxicological data demonstrating the vast potential 
for adverse immune effects following exposure to metal nanomaterials, advancements in 
understanding their interactions with biological systems have allowed for their unique 
characteristics to be harnessed for beneficial applications, as well. Numerous studies have 
demonstrated the potential utility of metal nanomaterials for novel vaccine adjuvants, drug 
delivery vehicles, diagnostic approaches, and immunotherapies. However, to optimize the 
use of metal-based nanomaterials for these and other advantageous purposes, a more 
complete understanding of their systemic immune effects, mechanisms of 
immunomodulation, and capacity to induce allergic sensitization is needed.
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Figure 1. 
Different morphologies of nanomaterials are shown: (a) graphene sheets, (b) silver 
nanoparticles, (c) silver nanowires, (d) gold nanorods, (e) gold nanoparticles, (f) nickel 
oxide nanoparticles, and (g) copper oxide nanoparticles.
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Figure 2. 
Steps of the Adverse Outcome Pathway (AOP) for dermal sensitization adapted from the 
Organization for Economic Cooperation and Development (OECD).
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Figure 3. 
Potential adverse outcomes with respect to the sensitization and elicitation phases of allergy 
following exposure to immunotoxic agents. Adjuvant effects resulting from exposure prior 
to allergen sensitization can manifest as increased susceptibility to sensitization. Exposure 
concurrent to sensitization may lower the threshold of allergen exposure required to induce 
sensitization. Following sensitization to allergen, exposure to an immunotoxic agent either in 
the absence or presence of allergen may result in a lower threshold of exposure required to 
induce elicitation reactions or increased severity of elicitation symptoms. These effects may 
further increase susceptibility to elicitation reactions as result of physiological alterations 
such as compromised skin barrier integrity. Furthermore, isolated exposure to immunotoxic 
agents or concurrent to allergens in established allergic disease conditions may also 
contribute to the progression of chronic effects, such as airway remodeling, which can also 
further contribute to elicitation reactions.
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